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1. General Experimental:  
 
All reactions were performed under nitrogen unless otherwise stated. Melting points were 
determined using Stuart Scientific SMP1 melting point apparatus and are uncorrected. 
Infrared spectra were recorded on Mattson 5000 FTIR and Perkin-Elmer Spectrum RX FT-IR 
System spectrometers. Proton nuclear magnetic resonance (
1
H NMR) and carbon nuclear 
magnetic resonance (
13
C NMR) spectra were recorded in CDCl3 unless otherwise stated on a 
Jeol GX-270, Brüker DRX-300, Brüker AV-400 or Brüker AV-500 spectrometer. Chemical 
shifts are in parts per million (ppm) and are referenced relative to the residual proton-
containing solvent (
1
H NMR: 7.26 ppm for CDCl3; 
13
C NMR: 77.0 ppm for CDCl3). Mass 
spectra (CI, EI and FAB) were recorded using Micromass AutoSpec-Q, Micromass Platform 
II or Micromass AutoSpec Premier instruments. Elemental analyses were performed at the 
microanalytical laboratories of the London Metropolitan University. Optical rotations were 
measured on an Optical Activity Ltd. instrument. Analytical thin layer chromatography (TLC) 
was performed on pre-coated Aluminium-backed Merck Kieselgel 60 F254 plates. 
Visualisation was effected with ultraviolet light, potassium permanganate or vanillin as 
appropriate. Flash chromatography was performed using BDH (40–63 μm) silica gel unless 
otherwise stated. Standard solvents were distilled under nitrogen prior to use; Et2O and THF 
from sodium-benzophenone ketyl, CH2Cl2 from CaH2 and toluene from sodium. All other 
solvents were reagent grade. Petrol refers to petroleum ether of the fraction bp 40–60 °C. All 
liquid reagents were distilled prior to use. BSA was purchased from Alfa Aesar Lancaster and 
distilled prior to use. Potassium acetate was oven-dried at 120 °C for several days prior to use. 
Microwave reactions were performed in a Biotage initiator. 
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2. General Procedures 
General Procedure A: preparation of cyclic orthoesters from1,4-diols 
To a solution of the diol (1.0 equiv.) in CH2Cl2 was added CSA (1 mol%) and 
trimethylorthoformate (2.0 equiv.). The reaction mixture was stirred at rt for 1 h 
before addition of NEt3. The mixture was concentrated under reduced pressure and 
purified by chromatography to give the desired orthoester. 
 
General Procedure B: preparation of allylic alcohols from cyclic orthoesters 
To a solution of the orthoester (1.0 equiv.) in PhMe at –78 °C was added DIBAL-H 
(1.3 equiv.) dropwise. The reaction mixture was allowed to warm to rt and stirred for 
16 h. The reaction mixture was again cooled to 0 °C, carefully quenched with sat. 
Na/K tartrate soln. and the mixture stirred for a further 1 h. The aqueous layer was 
then extracted with EtOAc and the combined organic layers washed with sat. aq. NaCl 
(×2) and H2O, dried (MgSO4) and concentrated under reduced pressure. Purification 
by chromatography gave the desired alkene. 
 
General Procedure C: preparation of mesylates from allylic alcohols 
To a solution of alcohol (1.0 equiv.) in CH2Cl2 at 0 °C was added NEt3 (3.0 equiv.). 
The reaction mixture was stirred at 0 °C for 15 min, and methanesulfonyl chloride 
(2.0 equiv.) was added dropwise. The reaction was stirred at 0 °C for 30 min, washed 
with 2 M aq. HCl (×2) and sat. aq.  NaHCO3 (×2). The organic phase was dried 
(MgSO4) and concentrated under reduced pressure to give the desired methane 
sulfonate 
 
General Procedure D: alkylation of sulfone- and sulfoximine-substituted acetates 
To a suspension of sodium hydride (60% dispersion in mineral oil, washed with 
hexane; 1.1 equiv.) in THF or DMF at 0 °C, was added dropwise a solution of the 
ester (1.0 equiv.) in THF or DMF. The reaction mixture was stirred at 0 °C for 30 min 
and a solution of the methane sulfonate or iodide (1.0 equiv.) in THF or DMF was 
added dropwise. The reaction mixture was stirred at 0 °C for a further 30 min, then at 
rt for 16 h. The solution was concentrated under reduced pressure and the crude 
product suspended in EtOAc, washed with sat. aq. NH4Cl, H2O and sat. aq. NH4Cl 
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The organic phase was dried (MgSO4), concentrated under reduced pressure and 
purified by chromatography to give the desired alkylated ester. 
 
General Procedure E: hydrolysis of MOM ethers/tert-butyl esters 
To a solution of the ester (1.0 equiv.) in MeCN was added 2 M aq. HCl The reaction 
mixture was heated under reflux for 2 h, cooled, and partitioned between CH2Cl2 and 
H2O. The aqueous phase washed with CH2Cl2 (×5). The combined organic washings 
were dried (MgSO4), concentrated under reduced pressure, and purified by 
chromatography to give the desired alcohol/hydroxyacid. 
 
General Procedure F: hydrolysis of methyl esters 
To a solution of the ester (1.0 equiv.) in THF was added 2 M aq. LiOH (5.0 equiv.). 
The reaction was stirred at rt for 1 h, then partitioned between Et2O and H2O and the 
aqueous layer acidified to pH 1 with 2 M aq. HCl. The aqueous layer was then 
extracted with Et2O (×3) and the organic layers combined, dried (MgSO4) and 
concentrated under reduced pressure to give, without further purification, the desired 
acid. 
 
General Procedure G: cyclisation of hydroxyacids to give unsaturated -lactones 
To a solution of the hydroxyacid (1.0 equiv.) in CH2Cl2 at 0 °C was added EDCI (1.1 
equiv.) portionwise. The reaction mixture was allowed to warm to rt and left to stir for 
16 h. The reaction mixture was partitioned between H2O and CH2Cl2, the organic 
layer washed with sat. aq. NH4Cl and H2O, dried (MgSO4) and concentrated under 
reduced pressure. The product was purified by chromatography to give the desired 
lactone. 
 
General Procedure H: dCr reaction of unsaturated -lactones  
A solution of lactone (1.0 equiv.), BSA (1.0 equiv.) and KOAc (0.1 equiv.) in DMF 
was subjected to microwave irradiation at 160 °C for 10 min. The reaction mixture 
was diluted with EtOAc, washed with sat. aq. NaCl (×3) and H2O, dried (MgSO4) and 
concentrated under reduced pressure to give the desired cyclopropane. 
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General Procedure I: preparation of 1,4-diols from furan-2(5H)-ones 
To a solution of furan-2(5H)-one (1.0 equiv.) in PhMe at −78 °C was added DIBAL-
H (2.2 equiv.) dropwise. The reaction mixture was allowed to stir at –78 °C for 2 h, 
then warmed to rt and stirred for a further 2 h. The reaction mixture was again cooled 
to 0 °C and carefully quenched with sat. Na/K tartrate soln. and the mixture stirred for 
a further 1 h. The aqueous layer was then extracted with EtOAc and the combined 
organic layers washed with sat. aq. NaCl (×2) and H2O, dried (Na2SO4) and 
concentrated under reduced pressure. Purification by chromatography gave the 
desired 1,4-diol. 
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3. Synthesis and reactions of lactone 13 
 
Methanesulfonic acid (Z)-4-(methoxymethoxy)but-2-enyl ester 9 
 
According to general procedure C, alcohol 8
1
 (1.72 g, 13.0 mmol, 1.0 equiv.) in 
CH2Cl2 (65 mL) was reacted with NEt3 (5.44 mL, 39.0 mmol, 3.0 equiv.) and 
methanesulfonyl chloride (2.01 mL, 26.0 mmol, 2.0 equiv.) to give methanesulfonic 
acid (Z)-4-(methoxymethoxy)but-2-enyl ester 9 as an orange oil, which was used 
crude in the next step; Rf 0.17 (50% EtOAc–petrol); H (270 MHz, CDCl3) [5.94–
5.85, 5.82–5.71] (2H, 2 × m, CH=CH), 4.84 (2H, d, J 6.5 Hz, CHCH2OS), 4.62 (2H, 
s, OCH2O), 4.17 (2H, d, J 6.5 Hz, CHCH2OMOM), 3.37 (3H, s, OCH3), 3.01 (3H, s, 
SCH3); C (67.5 MHz, CDCl3) 132.6 (CHCH2OMOM), 124.9 (CHCH2OMs), 95.8 
(OCH2O), 65.3 (CH2OS), 62.7 (=CH-CH2O), 55.5 (OCH3), 38.1 (SCH3). 
 
(Z)-tert-Butyl 6-(methoxymethoxy)-2-tosylhex-4-enoate 11 
 
According to general procedure D, a suspension of sodium hydride (766 mg, 31.9 
mmol, 1.1 equiv.) in THF (50 mL) was treated with a solution of ester 10
2
 (7.84 g, 
29.0 mmol, 1.0 equiv.) in THF (50 mL) followed by a solution of methanesulfonic 
acid (Z)-4-(methoxymethoxy)but-2-enyl ester 9 (29.0 mmol, 1.0 equiv.) in THF (40 
mL). Purification by chromatography (20% EtOAc–petrol) gave (Z)-tert-butyl 6-
(methoxymethoxy)-2-tosylhex-4-enoate 11 (6.95 g, 57% over two steps) as a yellow 
oil; Rf 0.32 (35% EtOAc–petrol); max (film) 1732, 1699, 1597, 1456, 1396, 1369, 
1327, 1306, 1292, 1246, 1213, 1147, 1105, 1086, 1047, 993, 947, 920, 883, 837, 816, 
760, 714, 667 cm
-1
; H (500 MHz, CDCl3) 7.74 (2H, d, J 8.5 Hz, o-SO2Ar), 7.33 (2H, 
d, J 8.5 Hz, m-SO2Ar), [5.68-5.63, 5.44-5.39] (2H, m, -CH=CH-), 4.58 (2H, s, -
OCH2O-), [4.10, 4.01] (2× 1H, dd, J 12.5, 6.5 Hz, =CH-CH2O-), 3.84 (1H, dd, J 10.5, 
4.5 Hz, Ts-CH<), 3.32 (3H, s, -OCH3), 2.75-2.70 (2H, m, Ts-CH-CH2-CH=), 2.43 
(3H, s, Ts-CH3), 1.31 (9H, s, -C(CH3)3); C (75 MHz, CDCl3) 164.4 (C=O), 145.3 
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(4°), 134.4 (4°), 130.2 (3°), 129.6 (3°), 129.4 (3°), 126.2 (3°), 95.8 (-OCH2O-), 83.3 (-
C(CH3)3), 70.6 (Ts-CH-COO-), 62.8 (-OCH2-CH=), 55.3 (-OCH3), 27.6 (-C(CH3)3), 





, 346, 323, 314, 302, 288, 284, 232, 197, 192, 174, 139 (Found: 
[M+NH4]
+
, 402.1948. C19H28O6S requires [M+NH4]
+
, 402.1950) (Found: C, 59.21; H, 
7.37. C19H28O6S requires C, 59.35; H, 7.34%). 
 
(Z)-6-Hydroxy-2-tosylhex-4-enoic acid 12 
 
According to general procedure E, ester 11 (882 mg, 2.29 mmol, 1.0 equiv.) was 
heated under reflux in MeCN (25 mL) and 2 M aq. HCl (5 mL). Purification by 
recrystallisation from CHCl3–petrol gave (Z)-6-hydroxy-2-tosylhex-4-enoic acid 12 
(577 mg, 81%) as a colourless crystalline solid; mp 124–126 °C; max (film) 3480, 
3029, 1732, 1597, 1444, 1401, 1383, 1319, 1303, 1292, 1246, 1146, 1084, 1016, 815, 
711, 663 cm
-1
; H (300 MHz, DMSO-d6) 7.75 (2H, d, J 7.0 Hz, o-SO2Ar), 7.47 (2H, d, 
J 7.0 Hz, m-SO2Ar), [5.60-5.53, 5.30-5.22] (2H, m, -CH=CH-), 4.20 (1H, dd, J 7.5, 
3.5 Hz, Ts-CH<), 3.99-3.83 (2H, m, HO-CH2-), 2.56-2.50 (2H, m, Ts-CH-CH2-CH=), 
2.42 (3H, s, Ts-CH3); C (75 MHz, DMSO-d6) 166.8 (C=O), 145.5, 134.8, 134.6, 
130.2, 129.4, 123.9, 69.6, 57.2, 25.4, 21.6; m/z (CI) 284 [M+NH4-H2O]
+
, 258, 240, 
223, 174, 156, 139, 130 (Found: [M+NH4-H2O]
+
, 284.0968. C13H16O5S requires 
[M+NH4-H2O]
+





According to general procedure G, (Z)-6-hydroxy-2-tosylhex-4-enoic acid 12 (2.50 g, 
8.80 mmol, 1.0 equiv.) in CH2Cl2 (150 mL) was treated with 
N,N’diisopropylcarbodiimide (1.51 mL, 9.67 mmol, 1.1 equiv.). Purification by 
chromatography (30% EtOAc–petrol) gave 3-tosyl-4,7-dihydrooxepin-2(3H)-one 13 
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(1.83 g, 78%) as a colourless powder; mp 144–146 °C; Rf 0.56 (50% EtOAc–petrol); 
max (film) 3041, 1745, 1597, 1471, 1435, 1400, 1387, 1352, 1321, 1257, 1225, 1176, 
1146, 1084, 1049, 1016, 943, 912, 879, 816, 800, 766, 729, 706, 660 cm
-1
; H (500 
MHz, CDCl3) 7.98 (2H, d, J 8.0 Hz, o-SO2Ar), 7.38 (2H, d, J 8.0 Hz, m-SO2Ar), 
[5.92-5.88, 5.86-5.82] (2H, m, -CH=CH-), [4.91 (app d quint, J 15.5, 3.0 Hz), 4.46 
(ddd, J 15.0, 7.0, 1.0 Hz)], (2H, -OCH2-), 4.70 (1H, dd, J 13.0, 4.0 Hz, Ts-CH<), 
[3.16-3.10, 2.69-2.61], (2H, m, Ts-CH-CH2-CH=), 2.45 (3H, s, Ts-CH3); C (67.5 
MHz, CDCl3) 166.7 (C=O), 145.7 (4°), 133.6, (4°), 130.6 (3°), 129.7 (3°), 129.5 (3°), 
124.3, (3°), 64.3 (Ts-CH<), 64.0 (-OCH2-), 27.1 (Ts-CH-CH2-CH=), 21.8 (Ts-CH3); 
m/z (CI) 284 [M+NH4]
+
, 189, 174, 130, 77 (Found: [M+NH4]
+
, 284.0957. C13H14O4S 
requires [M+NH4]
+
, 284.0957) (Found: C, 58.51; H, 5.47. C13H14O4S requires C, 
58.63; H, 5.30%). 
 
(1R*,2S*)-1-Tosyl-2-vinylcyclopropanecarboxylic acid 14 
 
A solution of lactone 13 (150 mg, 560 μmol, 1.0 equiv.) in CH2Cl2 (6 mL) was treated 
with KOAc (5.5 mg, 56.0 μmol, 0.1 equiv.) and BSA (140 l, 560 μmol, 1.0 equiv.). 
The reaction mixture was stirred at rt for 16 h, then diluted with CH2Cl2, washed with 
2 M aq. HCl and H2O, dried (MgSO4) and concentrated under reduced pressure to 
give (1R*,2S*)-1-tosyl-2-vinylcyclopropanecarboxylic acid 14 (150 mg, 100%) as a 
colourless solid; mp 118–120 °C; max (nujol) 3339, 2717, 2590, 1694, 1596, 1318, 
1289, 1145, 1084, 929, 817, 726, 665 cm
-1
; H (270 MHz, DMSO-d6) 7.78 (2H, d, J 
8.0 Hz, o-SO2Ar), 7.33 (2H, d, J 8.0 Hz, m-SO2Ar), 5.58 (1H, ddd, J 17.0, 10.0, 8.5 
Hz, CH=CH2), 5.39 (1H, dd, J 17.0, 1.5 Hz, CH=CH2 cis), 5.22 (1H, dd, J 10.0, 1.5 
Hz, CH=CH2 trans), 3.02 (1H, m, SCCH), 2.44 (3H, s, ArCH3), 2.16 (1H, dd, J 10.0, 
5.5 Hz, SCCH2), 1.96 (1H, dd, J 8.5, 5.5 Hz, SCCH2); C (100 MHz, DMSO-d6) 168.0 
(C=O), 145.2, 136.0 (4°), 130.6, 129.8, 128.8 (3°), 121.2 (CH=CH2), 50.5 (SC), 33.0 
(SCCH), 21.7 (ArCH3), 20.3 (SCCH2); m/z (CI) 284 [M+NH4]
+
, 242, 240, 174, 162, 
145, 102, 85  (Found: [M+NH4]
+






p-Tolyl (1R*,2S*)-2-vinylcyclopropyl sulfone 15 
 
According to general procedure H, lactone 13 (150 mg, 560 μmol, 1.0 equiv.) in DMF 
(mL) was treated with BSA (140 l, 560 μmol, 1.0 equiv.) and KOAc (5.53 mg, 56.0 
μmol, 0.1 equiv.) to give p-tolyl (1R*,2S*)-2-vinylcyclopropyl sulfone 15 (110 mg, 
88%) as a yellow oil; Rf 0.59 (50% EtOAc–petrol); max (film) 3086, 3041, 2925, 
1639, 1598, 1495, 1444, 1402, 1343, 1313, 1147, 1089, 942, 914, 858, 816, 743, 666, 
646 cm
-1
; H (400 MHz, DMSO-d6) 7.76 (2H, d, J 8.0 Hz, o-SO2Ar), 7.44 (2H, d, J 
8.0 Hz, m-SO2Ar), 5.38 (1H, ddd, J 17.0, 10.0, 8.5 Hz, CH=CH2), 5.22 (1H, d, J 17.0 
Hz, CH=CH2 cis), 4.97 (1H, d, J 10.0 Hz, CH=CH2 trans), 2.95 (1H, m, SCH), 2.40 
(3H, s, ArCH3), 2.24 (1H, m, SCHCH), [1.44, 1.17] (2H, 2 × m, SCHCH2); C (100 
MHz, DMSO-d6) 144.0, 137.6 (4°), 136.1, 129.9, 127.1 (3°), 116.1 (CH=CH2), 38.7 
(SCH), 22.3 (SCHCH), 21.0 (ArCH3), 12.3 (SCHCH2); m/z (CI) 240 [M+NH4]
+
, 223, 
84, 67 (Found [M+NH4]
+













Phenylboronic acid (76 mg, 0.62 mmol, 1.0 equiv.), 4-bromofuran-2(5H)-one
3
 (100 
mg, 0.62 mmol, 1.0 equiv.) and PdCl2(PPh3)2 (8.7 mg, 2.0 mol%) in 2 M aq. KF (2 
mL) and THF (2 mL) were heated under reflux for 5 h. After cooling to rt the layers 
were separated and the aqueous layer further extracted with EtOAc (×3). The 
combined organic extracts were washed with sat. aq. NaCl, dried (MgSO4) and 
concentrated under reduced pressure to give 4-phenylfuran-2(5H)-one as a colourless 
solid; Rf 0.57 (1% AcOH–EtOAc); max (film) 3111, 2929, 1793, 1734, 1621, 1450, 
1331, 1167, 1048, 894, 862, 771, 684 cm
-1
; H (400 MHz) 7.50 (5H, m, Ph), 6.38 (1H, 
t, J 1.5 Hz, CH), 5.23 (2H, d, J 1.5 Hz, CH2); C (100 MHz) 173.9 (C=O), 163.9, 
131.8 (4°), 129.7, 129.3, 126.4 (3°), 113.1 (CH), 71.0 (CH2); m/z (CI) 178 [M+NH4]
+
; 












According to general procedure I, a solution of 4-phenylfuran-2(5H)-one (950 mg, 
5.93 mmol, 1.0 equiv.) in PhMe (10 mL) was treated with DIBAL-H (1.7 M in PhMe; 
7.68 mL, 13.0 mmol, 2.2 equiv.). Purification by chromatography (50–70% EtOAc–
petrol) gave (Z)-2-phenylbut-2-ene-1,4-diol (793 mg, 81%) as a colourless oil; Rf 0.08 
(50% EtOAc–petrol); max (film) 3298, 2885, 1685, 1598, 1493, 1445, 1000, 758, 697 
cm
–1
; H (300 MHz) 7.45 (2H, m, m-Ph), 7.35 (3H, m, o-/p–Ph), 6.12 (1H, t, J 7.0 Hz, 
CH), 4.59 (2H, s, CCH2OH), 4.42 (2H, d, J 7.0 Hz, CHCH2), 2.04 (2H, s, OH); C (75 
MHz) 142.9, 140.4 (4°), 129.8, 128.6, 127.8, 126.4 (3°), 60.4 (CCH2OH), 59.0 
(CHCH2OH); m/z (CI) 182 [M+NH4]
+
, 164, 146, 118, 103, 91, 78; (Found [M+NH4]
+
, 
182.1175. C10H12O2 requires [M+NH4]
+
, 182.1176) (Found: C, 73.15; H, 7.37. 













According to general procedure A, a solution of (Z)-2-phenylbut-2-ene-1,4-diol (3.67 
g, 22.6 mmol, 1.0 equiv.) in CH2Cl2 (60 mL) was treated with CSA (52.5 mg, 0.23 
mmol, 1 mol%) and trimethyl orthoformate (4.96 mL, 45.3 mmol, 2.0 equiv.). 
Purification by chromatography (20–40% EtOAc–petrol) gave 2-methoxy-5-phenyl-
4,7-dihydro-1,3-dioxepine (3.64 g, 78%) as a colourless oil; Rf 0.59 (50% EtOAc–
petrol); max (film) 2940, 2869, 2842, 1599, 1494, 1446, 1344, 1279, 1209, 1133, 
1102, 1088, 1034, 753, 701 cm
–1
; H (300 MHz) 7.29 (5H, m, Ph), 5.88 (1H, tt, J 4.0, 
1.0 Hz, CHCH2), 5.47 (1H, s, OCH), 4.88 (1H, dd, J 15.5, 2.0 Hz, CCH2), 4.61 (1H, 
dddd J 16.0, 4.0, 2.0, 2.0 Hz, CHCH2), 4.50 (1H, ddd, J 16.0, 3.5, 1.5 Hz, CCH2), 
4.28 (1H, dddd, J 16.0, 4.0, 2.0, 2.0 Hz, CHCH2), 3.45 (3H, s, CH3); C (75 MHz) 
141.1, 139.5 (4°), 128.5, 127.5, 126.3, 126.1 (3°), 113.8 (CHO), 64.0 (CCH2O), 61.3 
(CHCH2O), 53.6 (CH3); m/z (ESI) 229 [M+Na]
+
, 206, 147, 129, 115, 91, 78 (Found 
[M+Na]
+
, 229.0835. C12H14O3 requires [M+Na]
+
, 229.0835) (Found: C, 69.79; H, 















According to general procedure B, a solution of 2-methoxy-5-phenyl-4,7-dihydro-1,3-
dioxepine (4.64 g, 22.5 mmol, 1.0 equiv.) in PhMe (4.0 mL) was treated with DIBAL-
H (1.2 M in PhMe; 41.2 mL, 49.5 mmol, 1.3 equiv.) Purification by chromatography 
(25% EtOAc–petrol) gave (Z)-4-methoxymethoxy-2-phenylbut-2-en-1-ol and (Z)-4-
methoxymethoxy-3-phenylbut-2-en-1-ol (3.73 g, 80%; ratio 69:31; separable by 
chromatography) as colourless oils; (Z)-4-methoxymethoxy-2-phenylbut-2-en-1-ol: Rf 
0.28 (50% EtOAc–heptane); max (film) 3411, 2934, 2884, 1493, 1445, 1377, 1149, 
1089, 1033, 1013, 945, 917, 766, 697 cm
-1
; H (300 MHz) 7.49 (2H, m, m-Ph), 7.39–
12 
7.29 (3H, m, o-/p-Ph), 6.04 (1H, t, J 7.0 Hz, CH), 4.71 (2H, s, OCH2O), 4.55 (2H, d, J 
6.5 Hz, CCH2OH), 4.35 (2H, d, J 7.0 Hz, CHCH2), 3.42 (3H, s, CH3), 2.37 (1H, t, J 
6.5 Hz, OH); C (75 MHz) 144.1, 140.5 (4°), 128.5, 127.8, 126.5, 126.4 (3°), 95.3 





, 226.1438. C12H16O3 requires [M+NH4]
+
, 226.1438) (Found: C, 
69.29; H, 7.72. C12H16O3 requires C, 69.21; H, 7.74); (Z)-4-methoxymethoxy-3-
phenylbut-2-en-1-ol: Rf 0.22 (50% EtOAc–heptane); max (film) 3388, 2932, 2883, 
1494, 1446, 1384, 1210, 1147, 1097, 1034, 945, 920, 757, 699 cm
-1
; H (300 MHz) 
7.48 (2H, m, m-Ph), 7.32 (3H, m, o-/p-Ph), 6.27 (1H, t, J 7.0 Hz, CH), 4.66 (2H, s, 
OCH2O), 4.56 (2H, s, CCH2), 4.38 (2H, d, J 6.5 Hz, CH2OH), 3.38 (3H, s, CH3); C 
(100 MHz) 140.5, 138.4 (4°), 131.8, 128.5, 127.7, 126.3 (3°), 95.1 (OCH2O), 63.7 
(CH2OH), 58.9 (CHCH2), 55.5 (OCH3); m/z (CI) 226 [M+NH4]
+
, 191, 161, 159, 131, 
129 (Found [M+NH4]
+
, 226.1438. C12H16O3 requires [M+NH4]
+
, 226.1438) (Found: 
C, 69.27; H, 7.80. C12H16O3 requires C, 69.21; H, 7.74). 
 








According to general procedure C, a solution of (Z)-4-methoxymethoxy-2-phenylbut-
2-en-1-ol (122 mg, 0.59 mmol, 1.0 equiv.) in CH2Cl2 (2 mL) was treated with NEt3 
(245 μL, 1.76 mmol, 3.0 equiv.) and MsCl (90.7 μL, 1.17 mmol, 2.0 equiv.) to give 
methanesulfonic acid (Z)-4-methoxymethoxy-2-phenylbut-2-enyl ester (162 mg, 96%) 
as a colourless oil which was without further purification; Rf 0.34 (50% EtOAc–
heptane); max (film) 3025, 2937, 2888, 1447, 1354, 1174, 1150, 1103, 1037, 929, 845, 
772, 699 cm
-1
; H (400 MHz) 7.43 (2H, m, o-Ph), 7.35 (3H, m, m-/p-Ph), 6.26 (1H, t, 
J 6.5 Hz, CH), 5.21 (2H, s, CCH2), 4.70 (2H, s, OCH2O), 4.39 (2H, d, J 6.5 Hz, 
CHCH2), 3.41 (3H, s, OCH3), 2.90 (3H, s, SCH3);C (100 MHz) 138.6, 135.6 (4°), 
132.0, 128.6, 128.3, 126.3 (3°), 96.0 (OCH2O), 65.8 (CH2OS), 63.3 (CHCH2), 55.5 

















To 4-bromofuran-2(5H)-one (2.0 g, 12.3 mmol, 1.0 equiv.) and PdCl2(PPh3)2 (172 
mg, 0.25 mmol, 2 mol%) in 2 M aq. KF (40 mL) and THF (40 mL) was added 2,4-
difluorophenylboronic acid (1.94 g, 12.3 mmol, 1.0 equiv.) and the mixture heated 
under reflux for 5 h. After cooling to rt the layers were separated and the aqueous 
layer extracted with EtOAc (×3). The combined organic phases were washed with sat. 
aq. NaCl, dried (Na2SO4) and concentrated under reduced pressure. Purification by 
chromatography (20–40% EtOAc–petrol) gave 4-(2,4-difluorophenyl)furan-2(5H)-
one (2.39 g, 99%) as a colourless solid; Rf 0.40 (50% EtOAc–petrol); max (film) 
3118, 3059, 1799, 1735, 1618, 1609, 1585, 1508, 1490, 1456, 1425, 1333, 1266, 
1163, 1148, 1106, 1049, 996, 961, 897, 888, 872, 809, 734 cm
-1
; H (300 MHz) 7.48 
(1H, m, o-ArF), 6.99 (2H, m, m-ArF), 6.49 (1H, t, J 2.0 Hz, CH), 5.24 (2H, d, J 2.0 
Hz, CH2); C (75 MHz) 173.4 (C=O), 166.5, 166.4, 163.3, 163.2, 163.1, 162.9, 159.9, 
159.7, (CF), 157.3 (4°), 129.5, 129.4 (3°), 115.9, 115.9, 115.8, 115.8 (CFCHCH), 
114.7, 114.6, 114.5 (CCF), 112.9, 112.8, 112.6, 112.6 (CFCHCH), 105.8, 105.4, 
105.1 (CFCHCF) 71.7 (CH2); m/z (EI) 214 [M+NH4]
+
, 197 (Found [M+H]
+
, 
197.0409. C10H6F2O2 requires [M+H]
+
, 197.0409) (Found: C, 61.29; H, 3.06. 















According to general procedure I, a solution of 4-(2,4-difluorophenyl)furan-2(5H)-
one (602 mg, 3.07 mmol, 1.0 equiv.) in PhMe (5 mL) was treated with DIBAL-H (1.7 
M in PhMe; 3.97 mL, 6.75 mmol, 2.2 equiv.). Purification by chromatography (50–
70% EtOAc–petrol) gave (Z)-2-(2,4-difluorophenyl)but-2-ene-1,4-diol (262 mg, 42%) 
as a colourless oil; Rf 0.10 (50% EtOAc–petrol); max (film) 3305, 2884, 1613, 1592, 
14 
1500, 1421, 1265, 1138, 1095, 997, 965, 847, 811, 723 cm
-1
; H (400 MHz) 7.28 (1H, 
m, o-ArF), 6.84 (2H, m, m-ArF), 6.00 (1H, t, J 6.5 Hz, CH), 4.49 (2H, s, CCH2OH), 
4.40 (2H, d, J 6.5 Hz, CHCH2), 2.22 (2H, br s, OH); C (100 MHz) 163.7, 163.6, 
161.2, 161.1, 160.9, 160.8, 158.7, 158.6 (CF), 138.2 (4°), 133.4 (3°), 131.1, 131.0 
(CFCHCH), 128.6, 128.5 (CCF), 111.6, 111.5, 111.4, 111.3 (CFCHCH), 104.3, 
104.1, 103.8 (CFCHCF), 61.1 (CCH2), 58.8 (CHCH2); m/z (CI) 218 [M+NH4]
+
, 182; 












According to general procedure A, a solution of (Z)-2-(2,4-difluorophenyl)but-2-ene-
1,4-diol (250 mg, 1.24 mmol, 1.0 equiv.) in CH2Cl2 (5 mL) was treated with CSA 
(14.5 mg, 0.062 mmol, 5 mol%) and trimethyl orthoformate (545 μL, 4.98 mmol, 4.0 
equiv.). Purification by chromatography (20–50% EtOAc–petrol) gave 5-(2,4-
difluorophenyl)-2-methoxy-4,7-dihydro-1,3-dioxepine (300 mg, 100%) as a 
colourless solid; mp 39–41°C; Rf 0.54 (50% EtOAc–heptane); max (film) 2942, 2845, 
1614, 1591, 1500, 1424, 1266, 1134, 1097, 1068, 1023, 966, 847, 798, 733 cm
-1
; H 
(300 MHz) 7.18 (1H, m, o-ArF), 6.80 (2H, m, m-ArF), 5.80 (1H, t, J 4.0 Hz, CHCH2), 
5.45 (1H, s, OCH), 4.74 (1H, ddd, J 15.5, 2.0, 2.0 Hz, CCH2), 4.59 (1H, dddd J 16.5, 
4.0, 2.0, 2.0 Hz, CHCH2), 4.39 (1H, dddd, J 15.5, 3.5, 2.0, 2.0 Hz, CCH2), 4.26 (1H, 
dddd, J 16.5, 4.0, 2.0, 2.0 Hz, CHCH2), 3.43 (CH3); C (75 MHz) 164.1, 164.0, 161.5, 
161.3, 160.8, 160.7, 158.2, 158.0 (CF), 136.5, (4°), 130.5, 130.3 (CFCHCH), 129.5, 
(3°), 124.0, 123.9, 123.8, 123.7 (CCF), 113.8 (CHO), 111.6, 111.5, 111.3, 111.2 
(CFCHCH), 104.5, 104.1, 103.8 (CFCHCF), 63.9, 63.8 (CCH2O), 61.1 (CHCH2O), 
53.7 (CH3); m/z (ESI) 265 [M+Na]
+





, 265.0647) (Found: C, 59.59; H, 4.89. C12H12F2O3 




















According to general procedure B, to a solution of 5-(2,4-difluorophenyl)-2-methoxy-
4,7-dihydro-1,3-dioxepine (781 mg, 3.22 mmol, 1.0 equiv.) in PhMe (8.3 mL) was 
treated with DIBAL-H (1.7 M in PhMe; 2.47 mL, 4.19 mmol, 1.3 equiv.). Purification 
by chromatography (20% EtOAc–petrol) gave (Z)-2-(2,4-difluorophenyl)-4-
(methoxymethoxy)but-2-en-1-ol and (Z)-3-(2,4-difluorophenyl)-4-(methoxy-
methoxy)but-2-en-1-ol (739 mg, 94%; ratio 68:32; separable by chromatography) as 
colourless oils; (Z)-2-(2,4-difluorophenyl)-4-(methoxymethoxy)but-2-en-1-ol: Rf 0.25 
(50% EtOAc–petrol); max (film) 3394, 2939, 2886, 1616, 1592, 1501, 1422, 1266, 
1139, 1097, 967, 850, 815 cm
-1
; H (300 MHz) 7.30 (1H, m, o-ArF), 6.83 (2H, m, m-
ArF), 5.90 (1H, t, J 7.0 Hz, CH), 4.71 (2H, s, OCH2O), 4.47 (2H, d, J 5.5 Hz, 
CCH2OH), 4.34 (2H, d, J 7.0 Hz, CHCH2), 3.41 (3H, s, CH3), 2.22 (1H, t, J 6.0 Hz, 
OH); C (100 MHz) 163.7, 163.5, 161.2, 161.1, 158.5, 158.6 (CF), 138.9 (4°), 131.1, 
131.0 (CFCHCH), 130.2 (3°), 125.1, 124.9 (CCF), 111.5, 111.4, 111.3, 111.2 
(CFCHCH), 104.3, 104.1, 103.8 (CFCHCF), 95.6 (OCH2O), 63.0 (CH2OH), 60.7, 
60.6 (CHCH2O), 55.4 (CH3); m/z (CI) 262 [M+NH4]
+
, 227, 183 (Found [M+NH4]
+
, 
262.1249. C12H14F2O3 requires [M+NH4]
+
, 262.1249) (Found: C, 58.92; H, 5.69. 
C12H14F2O3 requires C, 59.01; H, 5.78); (Z)-3-(2,4-difluorophenyl)-4-
(methoxymethoxy)but-2-en-1-ol: Rf 0.19 (50% EtOAc–petrol); max (film) 3404, 
2945, 2887, 1616, 1593, 1501, 1422, 1266, 1140, 1097, 1039, 1007, 966, 919, 850, 
815 cm
-1
; H (300 MHz) 7.29 (1H, m, o-ArF), 6.83 (2H, m, m-ArF), 6.07 (1H, t, J 7.0 
Hz, CH), 4.62 (2H, s, OCH2O), 4.47 (2H, s, CCH2), 4.37 (2H, t, J 6.0 Hz, CH2OH), 
3.34 (3H, s, CH3) 2.14 (1H, t, J 6.0 Hz, OH); C (75 MHz) 164.0, 163.9, 161.7, 161.5, 
160.7, 160.6, 158.4, 158.3 (CF), 134.9 (3°), 134.1(4°), 131.0, 130.9, 130.9, 130.8, 
(CFCHCH), 125.2, 125.1, 125.0, 124.9 (CCF), 111.4, 111.4, 111.2, 111.1 
(CFCHCH), 104.4, 104.0, 103.7 (CFCHCF), 95.4 (OCH2O), 64.4 (CH2OH), 58.7 
(CCH2) 55.5 (CH3); m/z (EI) 262 [M+NH4]
+




262.1249. C12H14F2O3 requires [M+NH4]
+
, 262.1249) (Found: C, 59.14; H, 5.67. 
C12H14F2O3 requires C, 59.01; H, 5.78). 
 










According to general procedure C, to a solution of (Z)-2-(2,4-difluorophenyl)-4-
(methoxymethoxy)but-2-en-1-ol (68 mg, 0.28 mmol, 1.0 equiv.) in CH2Cl2 (1 mL) 
was treated with NEt3 (116 μL, 0.84 mmol, 3.0 equiv.) and MsCl (43.1 μL, 0.56 
mmol, 2.0 equiv.) to give methanesulfonic acid (Z)-2-(2,4-difluorophenyl)-4-
(methoxymethoxy)but-2-enyl ester (84 mg, 93%) as a colourless oil, which was used 
without further purification; Rf 0.35 (50% EtOAc–petrol); max (film) 2942, 1615, 
1592, 1502, 1353, 1267, 1172, 1141, 1099, 1048, 1030, 920, 846, 807 cm
-1
; H (400 
MHz) 7.28 (1H, m, o-ArF), 6.86 (2H, m, m-ArF), 6.07 (1H, t, J 6.5 Hz, CH), 5.13 
(2H, s, CCH2), 4.69 (2H, s, OCH2O), 4.36 (2H, d, J 6.5 Hz, CHCH2), 3.41 (3H, s, 
OCH3), 2.92 (3H, s, SCH3); C (100 MHz) 164.0, 163.9, 161.5, 161.4, 161.2, 161.1, 
158.7, 158.6 (CF), 134.8 (4°), 134.8 (3°), 131.3, 131.3, 131.2, 131.2 (CFCHCH), 
123.1, 123.1, 123.0, 123.0 (CCF), 111.8, 111.8, 111.6, 111.5 (CFCHCH), 104.5, 
104.2, 104.0 (CFCHCF), 96.0 (OCH2O), 66.3, 66.3 (CHCH2), 63.0 (CCH2), 55.5 
(OCH3), 37.7 (SCH3); m/z (CI) 340 [M+NH4]
+















To 4-bromofuran-2(5H)-one (4.25 g, 26.1 mmol, 1.0 equiv.) and PdCl2(PPh3)2 (366 
mg, 0.52 mmol, 2 mol%) in 2 M aq. KF (87 mL) and THF (87 mL) was added 2,6-
difluorophenylboronic acid (4.12 g, 26.1 mmol, 1.0 equiv.) and the mixture heated 
under reflux for 5 h. After cooling to rt the layers were separated and the aqueous 
layer further extracted with EtOAc (×3). The combined organic phases were washed 
with sat. aq. NaCl, dried (MgSO4) and concentrated under reduced pressure. 
17 
Purification by chromatography (30–50% EtOAc–petrol) gave 4-(2,6-
difluorophenyl)furan-2(5H)-one (4.40 g, 86%) as a colourless solid; Rf 0.52 (50% 
EtOAc–petrol); max (film) 3055, 2987, 1758, 1626, 1466, 1265, 1167, 1071, 1053, 
1017, 896, 868, 791, 741, 704 cm
–1
; H (400 MHz) 7.45 (1H, tt, J 8.5, 6.5 Hz, p-ArF), 
7.04 (2H, dd, J 9.5, 8.5 Hz, m-ArF), 6.68 (1H, s, CH), 5.29 (2H, s, CH2); C (100 
MHz) 173.3 (C=O), 162.5, 162.4, 160.0, 159.9 (CF), 153.3 (CCH), 133.0, 132.9, 
132.8 (CFCHCH), 119.4, 119.3, 119.2 (CCH), 112.7, 112.4 (CHCF), 108.5, 108.4, 
108.2 (CCF), 73.1, 73.0 (CH2); m/z (CI) 197 [M+H]
+
, 410, 214 (Found [M+H]
+
, 
197.0421. C10H6F2O2 requires [M+H]
+
, 197.0414) (Found: C, 61.18; H, 2.99. 












According to general procedure I, 4-(2,6-difluorophenyl)furan-2(5H)-one (4.32 g, 
22.0 mmol, 1.0 equiv.) in PhMe (70 mL) was treated with DIBAL-H (1.2 M in PhMe; 
40.4 mL, 48.5 mmol, 2.2 equiv.). Purification by chromatography (50% EtOAc–
petrol) gave (Z)-2-(2,6-difluorophenyl)but-2-ene-1,4-diol (2.61 g, 60%) as a 
colourless oil; Rf 0.15 (50% EtOAc–petrol); max (film) 3338, 2886, 1622, 1586, 1462, 
1269, 1231, 1000, 788 cm
–1
; H (400 MHz) 7.22 (1H, tt, J 8.5, 6.5 Hz, p-ArF), 6.90 
(2H, t, J 8.0 Hz, m-ArF), 6.00 (1H, t, J 6.5 Hz, CCH), 4.46 (2H, s, CCH2), 4.45 (2H, 
d, J 7.0 Hz, CHCH2), 2.14 (2H, br s, OH); C (100 MHz) 161.6, 161.5, 159.1, 159.1 
(CF) 136.0 (CHCH2OH), 131.3 (CCH2), 128.9, 128.8 (CFCHCH), 118.1 (CCF),  
111.6, 111.5, 111.4, 111.3 (CFCH), 61.3 (CCH2), 58.9 (CHCH2); m/z (CI) 218 
[M+NH4]
+
, 200 (Found [M+NH4]
+
, 218.0999. C10H10F2O2 requires [M+NH4]
+
, 












According to general procedure A, (Z)-2-(2,6-difluorophenyl)but-2-ene-1,4-diol (1.60 
g, 7.99 mmol, 1.0 equiv.) in CH2Cl2 (20 mL) was treated with CSA (18.6 mg, 0.08 
mmol, 1 mol%) and trimethyl orthoformate (1.75 mL, 16.0 mmol, 2.0 equiv.). 
Purification by chromatography (20→50% EtOAc–petrol) gave 5-(2,6-
difluorophenyl)-2-methoxy-4,7-dihydro-1,3-dioxepine (1.77 mg, 91%) as a yellow 
liquid; Rf 0.67 (50% EtOAc–petrol); max (film) 2945, 2874, 2846, 1621, 1583, 1567, 
1463, 1388, 1344, 1270, 1230, 1212, 1136, 1035, 998, 915, 814, 784, 722 cm
–1
; H 
(400 MHz) 7.22 (1H, tt, J 8.5, 6.5 Hz, p-ArF), 6.91 (2H, t, J 8.0 Hz, m-ArF), 5.92 
(1H, t, J 3.5 Hz, CHCH2), 5.49 (1H, s, OCH), 4.69 (2H, m, CCH2), 4.38 (2H, m, 
CHCH2), 3.47 (3H, s, CH3); C (100 MHz) 161.4, 161.3, 158.9, 158.8 (CF) 132.3 
(CCH2), 129.7 (CHCH2), 128.9, 128.8, 128.7 (CFCHCH), 116.7 (CCF), 113.7 (CHO), 
111.7, 111.6, 111.5, 111.4 (CFCH), 63.9 (CCH2), 61.3 (CHCH2), 53.7 (CH3); m/z (CI) 
143 [M+H]
+
, 502, 260, 228, 211, 200, 182 (Found [M+H]
+
, 243.0841. C12H12F2O3 
requires [M+H]
+
, 243.0833) (Found: C, 59.58; H, 5.05. C12H12F2O3 requires C, 59.50; 
H, 4.99). 
 















According to general procedure B, 5-(2,6-difluorophenyl)-2-methoxy-4,7-dihydro-
1,3-dioxepine (2.78 g, 11.48 mmol, 1.0 equiv.) in PhMe (36.4 mL) was treated with 
DIBAL-H (1.2 M in PhMe; 21.0 mL, 25.3 mmol, 2.2 equiv.). Purification by 
chromatography (5→10% Et2O–CH2Cl2) gave (Z)-2-(2,6-difluorophenyl)-4-
(methoxymethoxy)but-2-en-1-ol and (Z)-3-(2,6-difluorophenyl)-4-methoxymethoxy-
but-2-en-1-ol (2.32 g, 82%; ratio 66:34; separable by chromatography) as colourless 
19 
oils; (Z)-2-(2,6-difluorophenyl)-4-(methoxymethoxy)but-2-en-1-ol: Rf 0.39 (20% 
Et2O–CH2Cl2); max (film) 3433, 2939, 1622, 1585, 1462, 1268, 1231, 1150, 1101, 
1043, 996, 788 cm
-1
; H (400 MHz) 7.21 (1H, tt, J 8.5, 6.5 Hz, p-ArF), 6.90 (2H, t, J 
8.0 Hz, m-ArF), 5.87 (1H, t, J 7.0 Hz, CH), 4.73 (2H, s, OCH2O), 4.42 (2H, s, 
CCH2OH), 4.37 (2H, d, J 7.0 Hz, CHCH2), 3.42 (3H, s, CH3), 2.16 (1H, br s, OH); C 
(100 MHz) 161.7, 161.6, 159.2, 159.1 (CF), 132.9 (CCH2), 132.4 (CHCH2), 129.0, 
128.9, 128.8 (CFCHCH), 118.3, 118.1, 117.9 (CCF), 111.5, 111.5, 111.4, 111.3 
(CFCH), 95.3 (OCH2O), 62.5 (CH2OH), 60.8 (CHCH2), 55.5 (CH3); m/z (CI) 262 
[M+NH4]
+
, 506, 230 (Found [M+NH4]
+
, 262.1265. C12H14F2O3 requires [M+NH4]
+
, 
262.1255) (Found: C, 59.01; H, 5.78. C12H14F2O3 requires C, 59.06; H, 5.78); (Z)-3-
(2,6-difluorophenyl)-4-(methoxymethoxy)but-2-en-1-ol: Rf 0.31 (20% Et2O–CH2Cl2); 
max (film) 3412, 2932, 1623, 1463, 1268, 1231, 1150, 1101, 1053, 995, 790 cm
–1
; H 
(400 MHz) 7.24 (1H, tt, J 8.5, 6.5 Hz, p-ArF), 6.92 (2H, t, J 8.0 Hz, m-ArF), 6.08 
(1H, t, J 7.0 Hz, CH), 4.65 (2H, s, OCH2O), 4.46 (2H, s, CCH2), 4.42 (2H, d, J 7.0 
Hz, CH2OH), 3.35 (3H, s, CH3) 2.11 (1H, br s, OH); C (100 MHz) 161.7, 161.6, 
159.2, 159.2 (CF) 137.2 (CHCH2), 128.9, 128.8, 128.7 (CFCHCH), 127.8 (CCH2), 
118.2, 118.0, 117.8 (CCF), 111.5, 111.4, 111.3 (CFCH), 95.0 (OCH2O), 64.1 
(CH2OH), 58.7 (CCH2) 55.4 (CH3); m/z (CI) 262 [M+NH4]
+
, 506, 230 (Found 
[M+NH4]
+
, 262.1263. C12H14F2O3 requires [M+NH4]
+
, 262.1255) (Found: C, 59.12; 
H, 5.69. C12H14F2O3 requires C, 59.01; H, 5.78). 
 










According to general procedure C, (Z)-2-(2,6-difluorophenyl)-4-
(methoxymethoxy)but-2-en-1-ol (349 mg, 1.43 mmol, 1.0 equiv.) in CH2Cl2 (7.2 mL) 
was treated with NEt3 (597 μL, 4.29 mmol, 3.0 equiv.) and MsCl (221 μL, 2.86 mmol, 
2.0 equiv.) to give methanesulfonic acid (Z)-2-(2,6-difluorophenyl)-4-
(methoxymethoxy)but-2-enyl ester as a colourless oil, used crude in the next step; Rf 
0.64 (50% EtOAc–petrol); max (film) 3436, 3004, 2934, 2887, 1622, 1586, 1464, 
1360, 1329, 1271, 1254, 1196, 1151, 1104, 1047, 999, 789, 735 cm
–1
; H (400 MHz) 
7.28 (1H, tt, J 8.5, 6.5 Hz, o-ArF), 6.93 (2H, t, J 8.0 Hz, m-ArF), 6.08 (1H, t, J 6.5 Hz, 
20 
CH), 5.11 (2H, s, CCH2), 4.69 (2H, s, OCH2O), 4.38 (2H, d, J 6.5 Hz, CHCH2), 3.40 
(3H, s, OCH3), 2.93 (3H, s, SCH3); C (100 MHz) 161.6, 161.5, 159.1, 159.1 (CF),  
137.3 (CCH2), 129.8, 129.7, 129.6 (CFCHCH), 125.1 (CHCH2), 116.2, 116.1, 115.9 
(CCF), 111.7, 111.7, 111.5, 111.5 (CFCHCH), 95.9 (OCH2O), 66.6 (CHCH2), 62.8 
(CCH2), 55.5 (OCH3), 37.9 (SCH3); m/z (CI) 340 [M+NH4]
+
, 102 (Found [M+NH4]
+
, 




















According to general procedure D, a suspension of sodium hydride (25 mg, 0.62 
mmol, 1.1 equiv.) in THF (0.3 mL) at 0 °C was treated with tert-butyl 2-tosylacetate 
10
2
 (153 mg, 0.57 mmol, 1.0 equiv.) in THF (0.4 mL) and methanesulfonic acid (Z)-
4-methoxymethoxy-2-phenylbut-2-enyl ester (162 mg, 0.57 mmol, 1.0 equiv.) in THF 
(0.3 mL) to give tert-butyl (E)-6-methoxymethoxy-4-phenyl-2-tosylhex-4-enoate 
which was used without further purification; Rf 0.48 (50% EtOAc–heptane);max 
(film) 2980, 2933, 1732, 1597, 1493, 1446, 1370, 1327, 1151, 1084, 1047, 919, 836, 
816, 766, 714, 699, 566 cm
-1
; H (400 MHz) 7.77 (2H, d, J 8.0 Hz, o-SO2Ar), 7.37 
(2H, d, J 8.0 Hz, m-SO2Ar), 7.29 (5H, m, Ph), 5.91 (1H, t, J 6.5 Hz, CHCH2OH), 4.66 
(2H, s, OCH2O), 4.32 (1H, dd, J 13.0, 7.0 Hz, CHCH2O), 4.18 (1H, dd, J 13.0, 6.0 
Hz, CHCH2O), 3.82 (1H, dd, J 4.5, 1.0 Hz, SCH), 3.39 (3H, s, OCH3), 3.25 (2H, m, 
CHCH2O), 2.48 (3H, s, ArCH3), 1.23 (9H, s, C(CH3)3); C (100 MHz) 164.3 (C=O), 
145.3, 139.9, 137.6, 134.3 (4°), 129.6, 129.4, 128.7, 128.6, 127.9, 126.5 (3°), 95.9 
(OCH2O), 83.1 (C(CH3)3), 69.4 (SCH), 64.0 (OCH2CH), 55.3 (OCH3), 27.5 





, 478.2260. C25H32O6S requires [M+NH4]
+
, 478.2263) (Found: C, 65.19; H, 














According to general procedure E, a solution tert-butyl (E)-6-methoxymethoxy-4-
phenyl-2-tosylhex-4-enoate (218 mg, 0.47 mmol, 1.0 equiv.) in MeCN (4.5 mL) was 
treated with 2 M aq. HCl (0.9 mL) to give (E)-6-hydroxy-4-phenyl-2-tosylhex-4-enoic 













According to general procedure G, a solution of (E)-6-hydroxy-4-phenyl-2-tosylhex-
4-enoic acid, (109 mg, 0.30 mmol, 1.0 equiv.) in CH2Cl2 (0.75 mL) was treated with 
EDCI (63 mg, 0.33 mmol, 1.1 equiv.). Purification by chromatography (30% EtOAc–
petrol) gave 5-phenyl-3-tosyl-4,7-dihydrooxepin-2(3H)-one 16a (69 mg, 35% over 
three steps) as a colourless solid; Rf 0.40 (50% EtOAc–petrol); max (film) 2925, 1739, 
1596, 1324, 1269, 1158, 1143, 1087, 1056, 1019, 815, 746, 692, 662 cm
-1
; H (300 
MHz) 7.99 (2H, d, J 8.5 Hz, o-SO2Ar), 7.39–7.29 (7H, m, m-SO2Ar and Ph), 6.07 
(1H, m, CHCH2O), [5.06, 5.00] (1H, 2 × dd, J 3.5, 3.5 Hz, SCH), [4.86, 4.82] (1H, 2 
× d, J 4.0 Hz, OCH2), [4.68, 4.62] (1H, 2 × d, J 7.5 Hz, OCH2), [3.57, 3.51] (1H, 2 × 
m, SCHCH2), 3.03 (1H, m, SCHCH2), 2.45 (3H, s, CH3); C (75 MHz) 166.6 (C=O), 
145.8, 141.4, 140.2, 133.5 (4°), 130.5, 129.7, 128.7, 125.9 (3°), 121.3 (CHCH2O), 
64.3 (SCH), 64.0 (OCH2), 29.7, 29.5 (SCHCH2), 21.8 (ArCH3); m/z (CI) 360 
[M+NH4]
+
, 187 (Found [M+NH4]
+
, 360.1263. C19H18O4S requires [M+NH4]
+
, 
360.1264) (Found: C, 66.63; H, 5.30. C19H18O4S requires C, 66.65; H, 5.30). 
 
((1R*,2R*)-2-Phenyl-2-vinylcyclopropyl) p-tolyl sulfone 17a and ((1R*,2S*)-2-










16a 17a 18a  
According to general procedure H, a solution of lactone 16a (27 mg, 0.08 mmol, 1.0 
equiv.) in DMF (0.4 mL) was treated with KOAc (0.8 mg, 0.008 mmol, 0.1 equiv.) 
and BSA (19.1μL, 0.08 mmol, 1.0 equiv.) to give a diastereomeric mixture (3:2) of 
((1R*,2R*)-2-phenyl-2-vinylcyclopropyl) p-tolyl sulfone 17a and ((1R*,2S*)-2-
phenyl-2-vinylcyclopropyl) p-tolyl sulfone 18a (20 mg, 87%), which were separable 
by chromatography (20% EtOAc–petrol) as colourless oils; 17a: Rf 0.57 (50% 




; H (400 Hz) 7.86 (2H, d, J 8.0 Hz, o-SO2Ar), 7.37 (2H, d, J 8.0 Hz, m-
SO2Ar), 7.24 (3H, m, o-/p-Ph), 7.04 (2H, dd, J 7.5, 1.5 Hz, m-Ph), 6.45 (1H, dd, J 
17.0, 10.5 Hz, CH=CH2), 5.18 (1H, dd, J 10.5, 1.0 Hz, CH=CH2 trans), 4.57 (1H, dd, 
J 17.0, 1.0 Hz, CH=CH2 cis), 2.89 (1H, dd, J 9.0, 6.0 Hz, SCH), 2.47 (3H, s, ArCH3), 
2.13 (1H, dd, J 6.0, 6.0 Hz, SCHCH2), 1.83 (1H, dd, J 9.0, 5.5 Hz, SCHCH2); C (100 
Hz) 144.4, 140.0, 138.2, 137.2 (4°), 129.7, 129.5, 128.5, 127.6, 127.5 (3°), 118.3 
(CH=CH2), 46.9 (SCH), 38.6 (SCHC), 21.7 (ArCH3), 19.4 (SCHCH2); m/z (CI) 316 
[M+NH4]
+
, 143 (Found [M+NH4]
+
, 316.1382. C18H18O2S requires [M+NH4]
+
, 
316.1371); 18a: Rf 0.50 (50% EtOAc–petrol); max (film) 3059, 2925, 1633, 1598, 
1495, 1446, 1323, 1298, 1266, 1149, 1087, 914, 737, 702 cm
-1
;H (400 Hz) 7.56 (2H, 
d, J 8.0 Hz, o-SO2Ar), 7.33–7.26 (7H, m, m-SO2Ar and Ph), 5.64 (1H, dd, J 17.0, 10.5 
Hz, CH=CH2), 5.02 (1H, dd, J 10.5, 0.5 Hz, CH=CH2 trans), 4.75 (1H, dd, J 17.0, 0.5 
Hz, CH=CH2 cis), 2.84 (1H, dd, J 8.5, 6.0 Hz, SCH), 2.43 (3H, s, ArCH3), 2.25 (1H, 
dd, J 6.0, 5.5 Hz, SCHCH2), 1.49 (1H, dd, J 8.5, 5.5 Hz, SCHCH2); C (100 Hz) 
144.1, 141.7, 138.2, 134.8 (4°), 130.6, 129.6, 128.1, 127.7, 127.6 (3°), 115.3 




























According to general procedure D, a suspension of sodium hydride (11.5 mg, 0.29 
mmol, 1.1 equiv.) in THF (0.3 mL) was treated with tert-butyl 2-tosylacetate 10 (71 
mg, 0.26 mmol, 1.0 equiv.) in THF (0.4 mL) followed by methanesulfonic acid (Z)-2-
(2,4-difluorophenyl)-4-(methoxymethoxy)but-2-enyl ester (84 mg, 0.26 mmol, 1.0 
equiv.) in THF (0.3 mL) to give tert-butyl (E)-4-(2,4-difluorophenyl)-6-
methoxymethoxy-2-tosylhex-4-enoate, which was used without further purification; 

















According to general procedure E, a solution of tert-butyl (E)-4-(2,4-difluorophenyl)-
6-methoxymethoxy-2-tosylhex-4-enoate (85 mg, 0.17 mmol, 1.0 equiv.) in MeCN 
(1.5 mL) was treated with 2 M aq. HCl (0.3 mL) to give (E)-4-(2,4-difluorophenyl)-6-















According to general procedure G, a solution of (E)-4-(2,4-difluorophenyl)-6-
hydroxy-2-tosylhex-4-enoic acid (77 mg, 0.19 mmol, 1.0 equiv.) in CH2Cl2 (0.5 mL) 
was treated with EDCI (41 mg, 0.21 mmol, 1.1 equiv.). Purification by 
chromatography (40% EtOAc–petrol) gave 5-(2,4-difluorophenyl)-3-tosyl-4,7-
dihydrooxepin-2(3H)-one 16b (73 mg, 74% over three steps) as a colourless solid; Rf 
0.36 (50% EtOAc–petrol); max (film) 1745, 1594, 1501, 1321, 1305, 1291, 1265, 
1139, 1084, 972, 850, 813, 670 cm
-1
; H (400 MHz) 7.95 (2H, d, J 8.5 Hz, o-SO2Ar), 
7.36 (2H, d J 8.0 Hz, m-SO2Ar), 7.17 (1H, td, J 8.5, 6.5 Hz, o-ArF), 6.90–6.79 (2H, 
m, m-ArF), 5.95 (1H, m, CHCH2O), [5.04, 4.99] (1H, 2 × dd, J 6.5, 3.5 Hz, SCH), 
[4.86, 4.81] (1H, 2 × d, J 4.0 Hz, OCH2), [4.67, 4.62] (1H, 2 × d, J 7.5 Hz, OCH2), 
[3.43, 3.37] (1H, 2 × m, SCHCH2), 3.01 (1H, m, SCHCH2), 2.45 (3H, s, CH3); C (75 
MHz) 166.3 (C=O), 164.6, 164.4, 161.3, 161.2, 161.2, 161.1, 158.1, 157.9 (CF), 
145.8, 136.8, 133.6 (4°), 130.4, 130.3, 130.3, 129.9 (CFCHCH), 130.5, 129.7, 125.1, 
(3°), 124.8, 124.7, 124.6, 124.5 (CCF), 111.9, 111.8, 111.6, 111.6 (CFCHCH), 104.9, 
104.5, 104.2 (CFCHCF), 64.4, 63.6 (OCH2), 63.7 (SCH), 30.0, 29.9 (SCHCH2), 21.7 









((1R*,2R*)-2-(2,4-Difluorophenyl)-2-vinylcyclopropyl) p-tolyl sulfone 17b and 














According to general procedure H, lactone 16b (70.0 mg, 0.20 mmol, 1.0 equiv.) in 
DMF (1.0 mL) was treated with KOAc (pinch) and BSA (46.0 μL, 0.20 mmol, 1.0 
equiv.) to give a diastereomeric mixture (3:2) of ((1R*,2R*)-2-(2,4-difluorophenyl)-2-
vinylcyclopropyl) p-tolyl sulfone 17b and ((1R*,2S*)-2-(2,4-difluorophenyl)-2-
vinylcyclopropyl) p-tolyl sulfone 18b (46 mg, 75%) as a colourless gum, separable by 
chromatography (10–20% EtOAc–petrol); 17b: Rf 0.55 max (film) 3056, 2926, 1618, 
1508, 1426, 1266, 1148, 1090, 738 cm
-1
; H (500 MHz) 7.84 (2H, d, J 8.0 Hz, o-
SO2Ar), 7.36 (2H, d, J 8.0 Hz, m-SO2Ar), 7.01 (1H, ddd, J 8.5, 8.5, 6.5 Hz, 
CFCHCH), 6.80 (1H, dddd, J 8.0, 8.0, 2.5, 1.0 Hz, CFCHCH), 6.72 (1H, ddd, J 10.0, 
9.0, 2.5 Hz, CFCHCF), 6.39 (1H, dd, J 17.0, 10.5 Hz, CH=CH2), 5.18 (1H, d, J 10.5 
Hz, CH=CH2 trans), 4.56 (1H, d, J 17.0 Hz, CH=CH2 cis), 2.84 (1H, dd, J 9.0, 6.5 
Hz, SCH), 2.47 (3H, s, ArCH3), 2.19 (1H, dd, J 6.0, 6.0 Hz, SCHCH2), 1.79 (1H, dd, 
J 9.0, 6.0 Hz, SCHCH2); C (100 MHz) 163.7, 163.6, 162.9, 162.8, 161.8, 161.7, 
160.9, 160.8 (CF), 144.4, 138.0 (4°), 139.9 129.7, 127.6 (3°), 133.5 (CCF), 118.7 
(CFCHCH), 115.4 (CH=CH2), 111.2, 111.1, 111.0 (CFCHCH), 104.3, 104.1, 103.9 
(CFCHCF), 45.4 (SCH), 29.7 (SCHC), 21.6 (ArCH3), 18.7 (SCHCH2); F (376 MHz) 
–109.3 (1F, ddd, J 16.5, 8.0, 6.5 Hz, p-CF); m/z (CI) 352 [M+NH4]
+
, 316 (Found 
[M+NH4]
+
, 352.1198. C18H16F2O2S requires [M+NH4]
+
, 352.1183); 18b: Rf 0.59 
(50% EtOAc–petrol); max (film) 3923, 1598, 1505, 1425, 1321, 1290, 1148, 1088, 
967, 851, 741, 659 cm
-1
; H (400 MHz) 7.66 (2H, d, J 8.0 Hz, o-SO2Ar), 7.45 (1H, dd, 
J 15.0, 8.5 Hz, CFCHCH), 7.32 (2H, d, J 8.0 Hz, m-SO2Ar), 6.90 (1H, dddd, J 9.0, 
9.0, 2.5, 1.0 Hz, CFCHCH), 6.80 (1H, ddd, J 10.5, 9.0, 2.5 Hz, CFCHCF), 5.55 (1H, 
dd, J 17.0, 10.5 Hz, CH=CH2), 5.04 (1H, d, J 10.5 Hz, CH=CH2 trans), 4.74 (1H, d, J 
17.0 Hz, CH=CH2 cis), 2.82 (1H, dd, J 8.5, 6.5 Hz, SCH), 2.45 (3H, s, ArCH3), 2.17 
(1H, dd, J 6.0, 6.0 Hz, SCHCH2), 1.64 (1H, dd, J 8.5, 6.0 Hz, SCHCH2); C (100 
MHz) 163.8, 163.6, 162.6, 162.4, 161.3, 161.2, 160.2, 160.0 (CF), 144.5, 137.7 (4°), 
26 
132.4, 132.3, 132.3, 132.2 (CCF), 135.5, 129.7, 127.6 (3°), 123.1, 123.0 (CFCHCH), 
117.6 (CH=CH2), 111.6, 111.6, 111.4, 111.4 (CFCHCH), 104.5, 104.2, 104.0 
(CFCHCF), 46.7 (SCH), 29.7 (SCHCH), 21.7 (ArCH3), 19.4 (SCHCH2); F (376 
MHz) –108.8 (1F, ddd, J 16.5, 8.5, 6.5 Hz, o-CF), –109.4 (1F, dd, J 17.5, 8.5 Hz, p-
CF); m/z (CI) 352 [M+NH4]
+
, 316, 298 (Found [M+NH4]
+
, 352.1198. C18H16F2O2S 
requires [M+NH4]
+


















According to general procedure D, sodium hydride (40.2 mg, 1.00 mmol, 1.2 equiv.) 
in DMF (1.5 mL) was treated with methyl 2-tosylacetate
Error! Bookmark not defined.
 (191 
mg, 0.84 mmol, 1.0 equiv.) in DMF (1.5 mL) and methanesulfonic acid (Z)-2-(2,6-
difluorophenyl)-4-(methoxymethoxy)but-2-enyl ester (0.84 mmol, 1.0 equiv.) in THF 
(1.2 mL) to give methyl (E)-4-(2,6-difluorophenyl)-6-methoxymethoxy-2-tosylhex-4-




According to general procedure E, methyl (E)-4-(2,6-difluorophenyl)-6-
methoxymethoxy-2-tosylhex-4-enoate (0.84 mmol, 1.0 equiv.) in MeCN (8.4 mL) 
was treated with 2 M aq. HCl (1.68 mL). Purification by chromatography (20→40% 
EtOAc–petrol) gave (E)-methyl 4-(2,6-difluorophenyl)-6-hydroxy-2-tosylhex-4-
enoate (277 mg, 80% over three steps) as a colourless gum; Rf 0.33 (50% EtOAc–
petrol);max (film) 3055, 2986, 1741, 1620, 1463, 1423, 1265, 1149, 1085, 895, 738 
cm
–1
; H (400 MHz) 7.70 (2H, d, J 8.0 Hz, o-SO2Ar), 7.35 (2H, d, J 8.0 Hz, m-
SO2Ar), 7.23 (1H, tt, J 8.5, 6.5 Hz, p-ArF), 6.87 (2H, t, J 8.0 Hz, m-ArF), 5.83 (1H, t, 
J 7.0 Hz, CHCH2OH), 4.36 (1H, dd, J 13.5, 7.5 Hz, CH2OH), 4.18 (1H, dd, J 13.5, 
6.5 Hz, CH2OH), 3.84 (1H, dd, J 12.0, 3.5 Hz, SCH), 3.59 (3H, s, OCH3), 3.29 (1H, 
27 
dd, J 14.0, 12.0 Hz, SCHCH2), 3.02 (1H, dd, J 14.0, 2.5 Hz, SCHCH2), 2.47 (3H, s, 
ArCH3); C (100 MHz) 166.3 (C=O), 161.5, 161.4, 159.0, 158.9 (CF), 145.7, 136.9, 
133.6 (4°), 129.8, 129.2 (3°), 129.6, 129.5, 129.4 (CFCHCH), 125.0 (CHCH2OH), 
117.2 (CCF), 111.7, 111.6, 111.5, 111.4 (CFCH), 69.0 (SCH), 58.6 (CH2OH), 53.1 
(OCH3), 28.0 (SCHCH2), 21.7 (ArCH3); m/z (CI) 428 [M+NH4]
+
, 410, 393, 272, 174; 
(Found [M+NH4]
+


















According to general procedure F, (E)-methyl 4-(2,6-difluorophenyl)-6-hydroxy-2-
tosylhex-4-enoate (270 mg, 0.66 mmol, 1.0 equiv.) in THF (1.65 mL) was treated 
with 2 M aq. LiOH (1.65 mL) to give (E)-4-(2,6-difluorophenyl)-6-hydroxy-2-
tosylhex-4-enoic acid (214 mg, 82%), which was used without further purification; 
max (film) 3416, 3055, 2986, 1731, 1622, 1464, 1324, 1265, 1232, 1149, 1084, 1001, 
815, 789, 738, 704 cm
–1
; H (400 MHz) 7.71 (2H, d, J 8.5 Hz, o-SO2Ar), 7.33 (2H, d, 
J 8.5, 0.5 Hz, m-SO2Ar), 7.23 (1H, tt, J 8.5, 6.5 Hz, p-ArF), 6.83 (2H, dd, J 8.5, 7.5 
Hz, m-ArF), 5.82 (1H, dd, J 7.5, 6.5 Hz, CHCH2OH), 4.42 (1H, dd, J 13.0, 8.5 Hz, 
CH2OH), 4.12 (1H, dd, J 13.0, 6.0 Hz, CH2OH), 3.81 (1H, dd, J 12.0, 3.0 Hz, SCH), 
3.30 (1H, dd, J 14.0, 12.0 Hz, SCHCH2), 2.96 (1H, dd, J 14.0, 2.0 Hz, SCHCH2), 2.44 
(3H, s, ArCH3); C (100 MHz) 168.2 (C=O), 161.5, 161.4, 159.0, 159.0 (CF), 145.8, 
135.9, 133.5 (4°), 129.9, 129.3 (3°), 129.8, 129.6, 129.5 (CFCHCH), 125.9 
(CHCH2OH), 117.3, 117.1, 116.9 (CCF), 111.8, 111.7, 111.6, 111.5 (CFCH), 68.7 
(SCH), 58.4 (CH2OH), 28.2 (SCHCH2), 21.8 (ArCH3); m/z (CI) 370 [M–CO2+NH4]
+
, 
412, 396, 352, 335, 174 (Found [M+NH4]
+
, 414.1185. C19H18F2O5S requires 
[M+NH4]
+
















According to general procedure G, (E)-4-(2,6-difluorophenyl)-6-hydroxy-2-tosylhex-
4-enoic acid (98 mg, 0.25 mmol, 1.0 equiv.) in CH2Cl2 (1.25 mL) was treated with 
EDCI (52.7 mg, 0.28 mmol, 1.1 equiv.). Purification by chromatography (30% 
EtOAc–petrol) gave 5-(2,6-difluorophenyl)-3-tosyl-4,7-dihydrooxepin-2(3H)-one 16c 
(73 mg, 74% over three steps) as a colourless solid; Rf 0.60 (50% EtOAc–petrol); max 
(film) 3139, 1748, 1622, 1463, 1398, 1321, 1267, 1231, 1144, 1084, 1002, 781, 735, 
666 cm
–1
; H (400 MHz) 7.95 (2H, d, J 8.5 Hz, o-SO2Ar), 7.36 (2H, d J 8.0 Hz, m-
SO2Ar), 7.28 (1H, td, J 8.5, 6.5 Hz, o-ArF), 6.92 (2H, dd, J 8.0, 8.0 Hz, m-ArF), 5.96 
(1H, m, CHCH2O), [5.06, 5.02] (1H, 2 × dd, J 3.5, 3.5 Hz, SCH), [4.87, 4.83] (1H, 2 
× d, J 4.0 Hz, OCH2), [4.68, 4.64] (1H, 2 × d, J 7.5 Hz, OCH2), 3.29 (1H, d, J 17.5 
Hz, SCHCH2), 3.02 (1H, m, SCHCH2), 2.45 (3H, s, CH3); C (100 MHz) 166.2 
(C=O), 161.0, 160.9, 158.5, 158.4 (CF), 145.7, 133.6, 130.6 (4°), 130.4, 129.6, (3°), 
130.0, 129.9, 129.8 (CFCHCH), 127.5 (CHCH2OH), 117.6 (CCF), 111.9, 111.8, 
111.7, 111.6 (CFCHCH), 64.4 (OCH2), 63.6 (SCH), 29.8 (SCHCH2), 21.7 (CH3); m/z 
(CI) 396 [M+NH4]
+
, 254, 242, 174 (Found [M+NH4]
+
, 396.1085. C19H16F2O4S 
requires [M+NH4]
+
, 396.1081) (Found: C, 60.38; H, 4.19. C19H16F2O4S requires C, 
60.31; H, 4.26). 
 
((1R*,2R*)-2-(2,6-Difluorophenyl)-2-vinylcyclopropyl) p-tolyl sulfone 17c and 












16c 17c 18c  
According to general procedure I, lactone 16c (63 mg, 0.17 mmol, 1.0 equiv.) in DMF 
(0.85 mL) was treated with KOAc (0.85 mg, 0.017 mmol, 0.1 equiv.) and BSA (41 
μL, 0.17 mmol, 1.0 equiv.) to give a diastereomeric mixture (2:3) of ((1R*,2R*)-2-
(2,6-difluorophenyl)-2-vinylcyclopropyl) p-tolyl sulfone 17c and ((1R*,2S*)-2-(2,6-
29 
difluorophenyl)-2-vinylcyclopropyl) p-tolyl sulfone 18c (47 mg, 82%) as a colourless 
oil, separable by chromatography (10% Et2O–petrol); 17c: Rf 0.34 (50% Et2O–petrol); 
max (film) 3054, 1625, 1467, 1321, 1265, 1151, 1090, 1008, 790, 738, 704, 653 cm
–1
; 
H (400 MHz) 7.84 (2H, d, J 8.0 Hz, o-SO2Ar), 7.34 (2H, d, J 8.0 Hz, m-SO2Ar), 7.21 
(1H, tt, J 8.5, 6.5 Hz, p-ArF), 6.80 (2H, t, J 8.0 Hz, m-ArF), 6.35 (1H, dd, J 17.0, 10.5 
Hz, CH=CH2), 5.17 (1H, d, J 10.5 Hz, CH=CH2 trans), 4.62 (1H, d, J 17.0 Hz, 
CH=CH2 cis), 2.91 (1H, dd, J 9.0, 6.5 Hz, SCHCH2), 2.46 (3H, s, ArCH3), 2.30 (1H, 
dd, J 6.5, 6.5 Hz, SCHCH2), 1.8 (1H, dd, J 9.0, 6.0 Hz, SCHCH2); C (100 MHz) 
162.9, 162.8, 160.4, 160.3 (CF), 144.4, 137.5 (4°), 134.5 (CH=CH2), 129.9, 129.8, 
129.7 (CFCHCH), 129.5, 128.1 (3°), 117.2 (CH=CH2), 111.8, 111.5 (CFCH), 46.6 





, 352.1183. C18H16F2O2S requires [M+NH4]
+
, 352.1183) (Found: C, 64.69; 
H, 4.75. C18H16F2O2S requires C, 64.65; H, 4.82); 18c: Rf 0.27 (50% Et2O–petrol); 
max (film) 1628, 1466, 1325, 1298, 1234, 1150, 1088, 1004, 910, 734 cm
–1
; H (400 
MHz) 7.68 (2H, d, J 8.0 Hz, o-SO2Ar), 7.32 (2H, d, J 8.0 Hz, m-SO2Ar), 7.30 (1H, tt, 
J 8.5, 6.5 Hz, p-ArF), 6.92 (2H, dd, J 17.0, 8.5 Hz, m-ArF), 5.56 (1H, dd, J 17.0, 10.5 
Hz, CH=CH2), 5.06 (1H, d, J 10.5 Hz, CH=CH2 trans), 4.82 (1H, d, J 17.0 Hz, 
CH=CH2 cis), 2.85 (1H, ddd, J 8.5, 6.5, 2.0 Hz, SCHCH2), 2.44 (3H, s, ArCH3), 2.23 
(1H, ddd, J 6.5, 6.5, 2.5 Hz, SCHCH2), 1.71 (1H, dd, J 9.0, 6.0 Hz, SCHCH2); C (125 
MHz) 163.5, 163.5, 162.8, 162.7, 161.5, 161.5, 160.8, 160.8 (CF), 144.3, 138.6, 138.1 
(4°), 134.5 (CH=CH2), 129.5, 129.6, 129.7 (CFCHCH), 129.7, 127.7 (3°), 115.2 
(CH=CH2), 112.4, 112.2, 112.2, 112.1 (CFCHCF), 111.8, 111.8, 111.7, 111.6, 111.4, 
111.4, 111.3, 111.2 (CFCH), 44.9 (SCH), 29.1 (SCHC), 21.6 (ArCH3), 18.9 (CH2); 




, 352.1197. C18H16F2O2S requires 
[M+NH4]
+
, 352.1183) (Found: C, 64.77; H, 4.73. C18H16F2O2S requires C, 64.65; H, 
4.82). 
30 











Thioanisole (5.87 mL, 50.0 mmol, 1.0 equiv.) and tetrabutylammonium bromide (0.81 
g, 2.50 mmol, 5.0 mol%) were dissolved in CH2Cl2 (100 mL). Solid chloramine-T 
trihydrate (dried under vacuum over P2O5; 15.5 g, 55.0 mmol, 1.1 equiv.) was slowly 
added with stirring and cooling in a water bath. After addition was complete the water 
bath was removed and stirring continued for 2 h. The reaction mixture was washed 
with cold 5% aq. NaOH and H2O (×2), the organic layer dried (MgSO4) and 
concentrated under reduced pressure. The crude sulfilimine was recrystallised from 
methanol–water (9:1) to give (±)-S-methyl-S-phenyl-N-tosylsulfilimine (13.9 g, 95%) 
as colourless needles; mp 130 °C; Rf 0.07 (20% EtOAc–petrol); max (nujol) 1593, 
1295, 1279, 1142, 1086, 1021, 989, 932, 826, 766, 746, 689, 652 cm
-1
; H (270 MHz) 
7.68 (4H, m, o-Ph, o-SO2Ar), 7.49 (3H, m, m-/p-Ph), 7.14 (2H, d, J 8.0 Hz, m-
SO2Ar), 2.82 (3H, s, SCH3), 2.33 (3H, s, ArCH3); C (100 MHz) 141.7, 141.2, 136.1 
(4°), 132.4, 129.9, 129.2, 126.2, 125.8 (3°), 39.1 (SCH3), 21.3 (ArCH3); m/z (CI) 294 
[M+H]
+














To a solution of the (±)-S-methyl-S-phenyl-N-tosylsulfilimine (13.5 g, 46.0 mmol, 1.0 
equiv.) in CCl4 (100 mL) and MeCN (100 mL) was added RuO2.xH2O (12.2 mg, 0.92 
mmol, 2.0 mol%). A solution of NaIO4 (19.7 g, 92.0 mmol, 2.0 equiv.) in H2O (200 
mL) was then added slowly (~30 min) and the reaction stirred for 90 min. The phases 
were separated and the aqueous layer extracted with CH2Cl2. The organic layers were 
combined and iPrOH (4.5 mL) added and the reaction mixture stirred for a further 1 h, 
then filtered over celite, dried (MgSO4), and concentrated under reduced pressure. 
The yellow/green crystals were washed with EtOH to give the (±)-S-methyl-S-phenyl-
N-tosylsulfoximine (11.8 g, 83%) as colourless crystals; mp 102 °C; max (nujol) 1597, 
1580, 1327, 1314, 1230, 1146, 1090, 1067, 982, 811, 754, 740, 689, 653 cm
-1
; H (270 
31 
MHz) 8.00 (2H, d, J 7.5 Hz, o-Ph), 7.84 (2H, d, J 8.5 Hz, o-SO2Ar), 7.72–7.56 (3H, 
m, m-/p-Ph), 7.24 (2H, d, J 8.5 Hz, m-SO2Ar), 3.41 (3H, s, SCH3), 2.38 (3H, s, 
ArCH3); C (67.5 MHz) 142.9, 140.7, 138.6 (4°), 134.5, 129.8, 129.4, 127.6, 126.7 
(3°), 46.7 (SCH3), 21.6 (ArCH3); m/z (CI) 327 [M+NH4]
+
, 294, 189, 52; data were in 














A solution of (±)-S-methyl-S-phenyl-N-tosylsulfoximine (11.8 g, 38.1 mmol, 1.0 
equiv.) was heated in conc. H2SO4 (20 mL) for 25 min at 120 °C. The reaction was 
cooled to rt, then poured into ice and neutralised using 2 M aq. NaOH. The reaction 
mixture was extracted with CH2Cl2 (×2), and the organic layer dried (MgSO4) and 
concentrated under reduced pressure to give (±)-S-methyl-S-phenylsulfoximine (5.83 
g, 99%) as a colourless oil; max (film) 3268, 3191, 3091, 3062, 3018, 1446, 1409, 
1320, 1222, 1097, 1070, 1029, 1010, 950, 769, 742, 690 cm
-1
; H (270 MHz) 7.99 
(2H, d, J 8.0 Hz, o-Ph), 7.64–7.50 (3H, m, m-/p-Ph), 3.07 (3H, s, SCH3); C (67.5 






















A solution of (–)-(R)-camphorsulfonic acid (4.28 g, 18.4 mmol, 0.5 equiv.) in dry 
acetone (distilled over P2O5; 30 mL) was added to a solution of (±)-S-methyl-S-
phenylsulfoximine (5.72 g, 36.9 mmol, 1.0 equiv.) in dry acetone (20 mL) at rt and 
stirred for 16 h. The precipitate was then filtered and washed with dry acetone (×3) to 
give (–)-(RS)-S-methyl-S-phenylsulfoximine-(–)-camphorsulfonic acid (5.40 g, 40% 
from a possible 50%) as a colourless powder; mp 172–174 °C; max (nujol) 1728, 1580 
1415, 1253, 1231, 1190, 1140, 1038, 669, 748 cm
-1
; H (270 MHz) 8.17 (2H, d, J 8.0 
Hz, o-Ph), 7.82–7.67 (3H, m, m-/p-Ph), 3.84 (3H, s, SCH3), [3.11 and 2.62] (2H, 2 × 
d, J 15.0 Hz, SCH2), [2.42, 2.24] (2H, 2 × m, SCH2CCH2), 1.96 (1H, dd, J 4.0, 4.0 
32 
Hz, CHCH2CO), 1.89 (1H, dd, J 8.0, 4.0 Hz, CHCH2CO), 1.80 (1H, d, J 18.5 Hz, 
CHCH2CO), 1.48 (1H, ddd, J 13.0, 9.5, 4.0 Hz, CHCH2CH2), 1.28 (1H, ddd, J 13.0, 
9.5, 4.0 Hz, CHCH2CH2), [0.95, 0.73] (6H, 2 × s, CSA
-
CH3); C (125 MHz, DMSO-
d6) 215.9 (C=O), 137.9 (4°), 130.2, 128.2, 125.5 (3°), 58.0 (SO2CH2C), 47.1 
(CCH3)2), 46.9 (SO2CH2), 43.5 (SCH3), 42.2 (CH2CO), 42.1 (CHCO), 26.3 
(SO2CH2CCH2), 24.1 (CH2CCO), 19.9, 19.5 (C(CH3)2); m/z (CI) 156; data were in 


















(–)-(RS)-S-Methyl-S-phenylsulfoximine-(–)-camphorsulfonic acid (8.2 g, 22.2 mmol, 
1.0 equiv.) was dissolved in dry pyridine (15 mL). Tosyl chloride (4.23 g, 22.2 mmol, 
1.0 equiv.) was added slowly and the reaction was stirred for 16 h. The reaction 
mixture was then poured onto H2O and extracted with CH2Cl2. The organic layers 
were combined, washed with 2 M aq. HCl (×2) and H2O, dried (MgSO4) and 
concentrated under reduced pressure to give (–)-(RS)-S-methyl-S-phenyl-N-
tosylsulfoximine (6.07 g, 88%) as a colourless crystalline solid; mp 106–107 °C; 
[α]D
22
 −40.0 (c 5.0, CH2Cl2); max (nujol) 2361, 1735, 1312, 1239, 1061, 965, 805, 
685, 651 cm
-1
; H (270 MHz) 7.99 (2H, d, J 8.0 Hz, o-Ph), 7.82 (2H, d, J 8.0 Hz, o-
SO2Ar), 7.72–7.55 (3H, m, m-/p-Ph), 7.23 (2H, d, J 8.0 Hz, m-SO2Ar), 3.41 (3H, s, 
SCH3), 2.38 (3H, s, ArCH3); C (67.5 MHz) 143.0, 140.7, 138.6 (4°), 134.5, 129.8, 
















To a suspension of sodium hydride (60% dispersion in mineral oil, washed in hexane; 
430 mg, 10.7 mmol, 2.2 equiv.) in THF (10 mL) was added dimethyl carbonate (8.50 
mL, >20 equiv.) and the reaction mixture stirred at reflux whilst a solution of (–)-(RS)-
S-methyl-S-phenyl-N-tosylsulfoximine (1.50 g, 4.85 mmol, 1.0 equiv.) in THF (15 
mL) was added dropwise. The stirred reaction mixture was heated under reflux 
33 
overnight, cooled on ice and then quenched with MeOH–AcOH (2:1, 15 mL). The 
solution was poured onto H2O and the product extracted with Et2O (×5). The 
combined organic layers were washed with sat. aq. NaHCO3 and H2O, dried (MgSO4) 
and concentrated under reduced pressure. The yellow oil was then treated with EtOH 
to give methyl (RS)-2-(N-tosylphenylsulfonimidoyl)acetate (1.39 g, 78%) as a 
colourless solid; mp 76–77 °C; [α]D
22 −32.2 (c 5.0, CH2Cl2); 
 
Rf 0.43 (50% EtOAc–
petrol);max (film) 1742, 1643, 1496, 1447, 1318, 1153, 814, 666 cm
-1
; H (270 MHz) 
7.99 (2H, d, J 7.5 Hz, o-Ph), 7.86 (2H, d, J 8.5 Hz, o-SO2Ar), 7.70 (1H, m, p-Ph), 
7.58 (2H, m, m-Ph), 7.25 (2H, d, J 8.5 Hz, m-SO2Ar), [4.79, 4.58] (2H, AB doublet, J 
14.5 Hz, CH2), 3.64 (3H, s, OCH3), 2.38 (3H, s, ArCH3); C (67.5 MHz) 162.2 (C=O), 
143.3, 140.4, 135.9 (4°), 135.0, 129.5, 129.4, 128.7, 126.8 (3°), 61.4 (CH2), 53.4 
(OCH3), 21.6 (ArCH3); m/z (CI) 385 [M+NH4]
+
, 279, 208, 189; data were in 


















According to general procedure D, a suspension of sodium hydride (0.42 g, 10.5 
mmol, 1.1 equiv.) in THF (10 mL) was treated with methyl (RS)-2-(N-
tosylphenylsulfon-imidoyl)acetate (3.49 g, 9.5 mmol, 1.0 equiv.) in THF (25 mL), 
followed by mesylate 9 (2.00 g, 9.50 mmol, 1.0 equiv.) in THF (15 mL). Purification 
by chromatography (20→40% EtOAc–petrol) gave a diastereomeric mixture (1:1) of 
methyl (RS,Z)-6-(methoxymethoxy)-2-(N-tosylphenylsulfonimidoyl)hex-4-enoate 
(3.68 g, 80%) as a colourless gum; Rf 0.42 (50% EtOAc–petrol); max (film) 2952, 
1746, 1598, 1447, 1321, 1245, 1152, 1087, 1061, 1018, 997, 815, 765, 685, 666 cm
-
1
;H (500 MHz) 7.96 (2H, m, o-Ph), 7.88 (2H, m, o-SO2Ar), 7.76 (1H, m, p-Ph), 7.63 
(2H, m, m-Ph), 7.28 (2H, m, m-SO2Ar), 5.71 (1H, dt, J 11.0, 6.5 Hz, OCH2CH), 5.40 
(1H, m, SCHCH2CH), [4.89, 4.64] (1H, dd, J 11.0, 3.5 Hz, SCH), [4.59, 4.57] (2H, 2 
× s, OCH2O), 4.08–3.98 (2H, m, CHCH2O), [3.74, 3.69]  (3H, 2 × s, CO2CH3), [3.35, 
3.33] (3H, 2 × s, CH2OCH3), [2.91–2.84, 2.72–2.54] (2H, 2 × m, SCHCH2), 2.42 (3H, 
s, ArCH3); C (125 MHz) 165.2, 164.0 (C=O), 143.1, 143.0, 140.7, 140.5, 134.4, 
133.8 (4°), 135.0, 135.0, 131.3, 131.2, 129.8, 129.7, 129.3, 126.7, 126.7, 124.7 (3°), 
34 
95.8 (OCH2O), 71.1, 70.4 (SCH), 62.6 (OCH2CH), 55.3 (CH2OCH3), 53.4, 53.3 
(CO2CH3), 26.4, 25.1 (SCHCH2), 21.6 (ArCH3); m/z (CI) 499 [M+NH4]
+
, 455, 450, 
420, 385, 313, 189 (Found [M+NH4]
+
, 499.1591. C22H27NO7S2 requires [M+NH4]
+
, 
499.1573) (Found: C, 54.89; H, 5.63; N, 2.92. C22H27NO7S2 requires C, 54.87; H, 















According to general procedure E, methyl (RS,Z)-6-(methoxymethoxy)-2-(N-
tosylphenylsulfonimidoyl)hex-4-enoate (1.40 g, 2.90 mmol, 1.0 equiv.) was heated 
under reflux in MeCN (30 mL) and 2 M aq. HCl (6 mL) to give methyl (RS,Z)-6-
hydroxy-2-(N-tosylphenylsulfonimidoyl)hex-4-enoate (1.13 g, 89%) as a viscous, 
colourless oil; Rf 0.13 (50% EtOAc–petrol); max (film) 3525, 2954, 1744, 1598, 1447, 
1318, 1242, 1153, 1088, 1062, 998, 815, 754, 685. 665 cm
-1
; H (400 MHz) 7.94 (2H, 
d, J 8.5 Hz, o-Ph), 7.87 (2H, m, o-SO2Ar), 7.76 (1H, m, p-Ph), 7.62 (2H, m, m-Ph), 
7.28 (2H, m, m-SO2Ar), 5.77 (1H, m, CHCH2OH), 5.35 (1H, m, SCHCH2CH), [4.99, 
4.67] (1H, dd, J 11.5, 3.5 Hz, SCH), 4.16–4.05 (2H, m, CH2OH), [3.76, 3.61] (3H, 2 
× s, OCH3), 2.96–2.84 (1H, m, SCHCH2), [2.77, 2.69] (1H, m, SCHCH2), 2.41 (3H, s, 
ArCH3); C (100 MHz) 165.6, 165.3 (C=O), 143.2, 143.0, 140.6, 140.4, 134.4, 133.3 
(4°), 135.2, 135.0, 133.9, 133.8, 129.8, 129.6, 129.4, 129.3, 124.0, 123.8 (3°), 71.2, 
70.5 (SCH), 58.1, 58.0 (CH2OH), 53.5, 53.4 (OCH3), 26.4, 25.0 (SCHCH2), 21.6 
(ArCH3); m/z (CI) 455 [M+NH4]
+





, 455.1311) (Found: C, 55.02; H, 5.27; N, 3.09. 

















According to procedure F, methyl (RS,Z)-6-hydroxy-2-(N-
tosylphenylsulfonimidoyl)hex-4-enoate (1.10 g, 2.51 mmol, 1.0 equiv.) in THF (6.3 
mL) was treated with 2 M aq. LiOH (6.3 mL, 2.00 mmol, 5.0 equiv.) to give (RS,Z)-6-
hydroxy-2-(N-tosylphenylsulfonimidoyl)hex-4-enoic acid (860 mg, 81%) as a 
colourless solid, which was used without further purification; mp 149–151 °C; H 
(400 MHz, DMSO-d6); 7.91–7.88 (2H, m, o-Ph), 7.85–7.79 (1H, m, p-Ph), 7.72–7.63 
(4H, m, o-SO2Ar and m-Ph), 7.35–7.31 (2H, m, m-SO2Ar), 5.82–5.75 (1H, m, 
CHCH2OH), 5.48–5.41 (1H, m, SCHCH2CH), 4.90 (1H, dd, J 11.5, 3.0 Hz, SCH), 
4.10 (2H, ddd, J 19.0, 13.0, 7.0 Hz, CH2OH), [2.82–2.80, 2.69–2.61] (2H, 2 × m, 
SCHCH2), 2.41 (3H, s, ArCH3);  C (100 MHz, DMSO-d6) 165.6, 165.5 (C=O), 143.1, 
143.0, 142.9, 141.1, 136.6, 135.1 (4°), 135.4, 135.2, 134.9, 133.6, 130.1, 130.0, 129.8, 
129.8, 129.8, 128.5, 126.4, 125.0, 122.9, 122.4 (3°) 70.3, 70.1 (SCH), 57.1, 57.1 




, 406, 392, 
296, 167, 125, 89, 77 (Found [M+H]
+
, 424.0887. C19H21NO6S2 requires [M+H]
+
, 
424.0889) (Found: C, 53.91; H, 4.94; N, 3.24. C19H21NO6S2 requires C, 53.88; H, 
















According to general procedure G, (RS,Z)-6-hydroxy-2-(N-
tosylphenylsulfonimidoyl)hex-4-enoic acid (0.84 g, 1.99 mmol, 1.0 equiv.) in CH2Cl2 
(5 mL) was treated with EDCI (0.42 g, 2.19 mmol, 1.1 equiv.). The product was 
purified by chromatography (20→50% EtOAc–petrol) to give (RS)-3-(N-
tosylphenylsulfonimidoyl)-4,7-dihydrooxepin-2(3H)-one 19 (0.68 g, 84%) as a 
colourless crystalline solid; mp 74–76 °C; Rf 0.26 (50% EtOAc–petrol); max (film) 
36 
3441 (br), 3056, 1748, 1598, 1448, 1386, 1316, 1265, 1151, 1087, 736 cm
-1
; H (500 
MHz) 8.14 (2H, d, J 7.5 Hz, o-Ph), 7.87 (2H, d, J 8.5 Hz, o-SO2Ar), 7.70 (1H, m, p-
Ph), 7.58 (2H, dt, J 7.5, 7.5 Hz, m-Ph), 7.28 (2H, m, m-SO2Ar), [6.03, 5.78] (1H, dd, J 
13.0, 4.0 Hz, SCH), 5.88 (2H, d, J 4.0 Hz, HC=CH), [5.11, 4.51] (2H, m, OCH2), 
[3.31, 3.15] (1H, dd, J 17.5, 3.5 Hz, SCHCH2), 2.45–2.36 (1H, m, SCHCH2), 2.40 
(3H, s, ArCH3); C (125 MHz) 166.4 (C=O), 143.2, 143.2, 140.40, 140.2, 133.0, 
132.8, (4°), 134.9, 131.1, 131.0, 129.3, 129.0, 128.9, 128.6, 126.7, 126.7, 124.9, 
124.5, (3°), 65.4, 65.3 (SCH), 64.2, 64.1 (OCH2), 28.9, 27.5 (SCHCH2), 21.5 
(ArCH3); m/z (CI) 423 [M+NH4]
+





, 423.1048) (Found: C, 56.21; H, 4.80; N, 3.52. 





















According to general procedure H, lactone 19 (50.0 mg, 120 μmol, 1.0 equiv.), was 
treated with BSA (30.5 l, 120 μmol, 1.0 equiv.) and KOAc (1.2 mg, 12.0 μmol, 0.1 
equiv.) in DMF (0.6 mL) to give a diastereomeric mixture (3:2, unassigned) of 
(RS,1R,2S)-S-phenyl-S-(2-vinylcyclopropyl)-N-tosylsulfoximine and (RS,1S,2R)-S-
phenyl-S-(2-vinylcyclopropyl)-N-tosylsulfoximine 21 (28.0 mg, 65%) as a colourless 
oil; Rf 0.50 (50% EtOAc–petrol); max (film) 3052, 2985, 2923, 2852, 1640, 1598, 
1447, 1421, 1316, 1264, 1151, 1070 cm
-1
; H (400 MHz) 7.96 (2H, m, o-Ph), 7.83 
(2H, d, J 8.0 Hz, o-SO2Ar), 7.70 (1H, t, J 7.5 Hz, p-Ph), 7.60 (2H, t, J 7.5 Hz, m-Ph), 
7.26 (2H, d, J 8.0 Hz, m-SO2Ar), 5.55 (1H, ddd, J 17.5, 10.0, 7.5 Hz, CH=CH2 
minor), 5.35 (1H, ddd, J 17.5, 10.0, 7.5 Hz, CH=CH2 major), 5.28 (1H, d, J 17.5 Hz, 
CH=CH2 cis minor), 5.15 (1H, d, J 10.0 Hz, CH=CH2 trans minor), 5.07 (1H, d, J 
17.0 Hz, CH=CH2 cis major), 5.01 (1H, d, J 10.0 Hz, CH=CH2 trans major), 2.70 
(1H, m, SCH major and minor), 2.63 (1H, m, SCHCH minor), 2.42 (3H, s, ArCH3), 
2.23 (1H, m, SCHCH major), 1.95 (1H, dt, J 10.0, 5.5 Hz, SCHCH2 major), 1.42 (1H, 
dt, J 8.0, 6.5 Hz, SCHCH2 major), 1.53 (1H, dt, J 10.0, 5.5 Hz, SCHCH2 minor), 1.16 
(1H, dt, J 8.0, 6.5 Hz, SCHCH2 minor); C (100 MHz) 142.8, 140.8, 138.7 (4°), 134.2, 
37 
134.1, 134.0, 129.6, 129.2, 127.7, 127.6, 126.6 (3°), 117.7, 117.4 (CH=CH2), 41.7, 
41.6 (SCH), 24.1, 23.3 (SCHCH), 21.5 (ArCH3), 14.4, 12.7 (SCHCH2); m/z (CI) 362 
[M+H]
+
, 379, 189, 52 (Found [M+H]
+
, 362.0888. C18H19NO3S2 requires [M+H]
+
, 
362.0885) (Found: C, 59.81; H, 5.26; N, 3.89. C18H19NO3S2 requires C, 59.81; H, 














To a solution of (+)-(SS)-S-methyl-S-phenylsulfoximine (8.40 g, 54.0 mmol, 1.0 
equiv.) in pyridine (45 mL) at –5 °C, was added DMAP (30 mg) and 2,4,6-
triisopropylphenylsulfonyl chloride (16.4 g, 54.0 mmol, 1.0 equiv.) to give a yellow 
solution. The reaction was heated at 60 °C for 2 h. The reaction was cooled to rt, 
poured into cold H2O and 2 M aq. HCl added. The organic layer was extracted with 
CH2Cl2, and then washed with 2 M aq. HCl and H2O, until pH 8 was achieved. The 
organic layer was dried (MgSO4) and concentrated under reduced pressure. The 
orange oil was treated with EtOH to give (+)-(SS)-S-methyl-S-phenyl-N-(2,4,6-
triisopropylphenylsulfonyl)sulfoximine (14.15 g, 59%) as a colourless solid; Rf 0.60 
(50% EtOAc–petrol); mp 139–141 °C; [α]D
20 +20.0 (c 5.0, CH2Cl2); max (film) 3055, 
2963, 2870, 1599, 1463, 1448, 1423, 1312, 1294, 1265, 1238, 1148, 1100, 1069, 741, 
704 cm
-1
; H (400 MHz) 8.02 (2H, d, J 8.0 Hz, o-Ph) 7.71 (1H, t, J 7.5 Hz, p-Ph) 7.61 
(2H, t, J 8.0 Hz, m-Ph), 7.14 (2H, s, m-SO2Ar), 4.40 (2H, sept, J 6.5 Hz, o-ArCH), 
3.44 (3H, s, SCH3), 2.90 (1H, sept, J 7.0 Hz, p-ArCH), 1.29–1.24 (18H, m, 
CH(CH3)2); C (100 MHz) 152.0, 149.0, 138.8, 137.2 (4°), 134.3, 129.6, 127.5, 123.4 
(3°), 47.0 (SCH3), 34.1 (p-ArCH), 29.3 (o-ArCH), 24.7, 24.6 (o-ArCH(CH3)2), 23.7 
(p-ArCH(CH3)2); m/z (CI) 439 [M+NH4]
+
, 422, 299, 208, 156, 141, 80; data were in 
















To sodium hydride (60% dispersion in mineral oil, washed with hexane; 68.0 mg, 
2.82 mmol, 2.5 equiv.) suspended in THF (2 mL) was added dimethyl carbonate (2 
38 
mL) and the reaction mixture stirred at reflux whilst a solution of (+)-(SS)-S-methyl-S-
phenyl-N-(2,4,6-triisopropylphenylsulfonyl)sulfoximine (500 mg, 1.13 mmol, 1.0 
equiv.) in THF (3 mL) was added dropwise. The stirred reaction was heated under 
reflux for 16 h, cooled on ice and quenched with MeOH–AcOH (2:1; 2 mL). The 
solution was poured on to H2O and the product extracted with Et2O (×5). The 
combined organic layers were washed with sat. aq. NaHCO3 and H2O, dried (MgSO4) 
and concentrated under reduced pressure. The yellow oil was then crystallised from 
EtOH to give (+)-methyl (SS)-2-(N-(2,4,6-triisopropylphenylsulfonyl)phenylsulfon-
imidoyl)acetate (0.29 g, 75%) as a colourless solid; mp 111–112 °C; Rf 0.40 (100% 
CH2Cl2); [α]D
20 +11.0 (c 5.0, CH2Cl2); max (film) 3055, 2960, 1749, 1599, 1265, 1149, 
1095, 1065, 738, 704 cm
-1
; H (400 MHz) 8.04 (2H, d, J 7.5 Hz, o-Ph), 7.74 (1H, t, J 
7.5 Hz, p-Ph) 7.62 (2H, t, J 8.0 Hz, m-Ph), 7.14 (2H, s, m-SO2Ar), [4.76, 4.62] (2H, 
AB doublet, J 14.5 Hz, CH2), 4.40 (2H, sept, J 6.5 Hz, o-ArCH), 3.68 (3H, s, OCH3), 
2.90 (1H, sept, J 7.0 Hz, p-ArCH), 1.29–1.21 (18H, m, CH(CH3)2); C (100 MHz) 
162.2, (C=O), 152.2, 149.1, 137.0, 136.5 (4°), 134.8, 129.4, 128.6, 123.5 (3°), 61.8 
(OCH3), 53.2 (CH2), 34.1 (p-ArCH), 29.3 (o-ArCH), 24.7, 24.6 (o-ArCH(CH3)2), 23.6 
(p-ArCH(CH3)2); m/z (CI) 497 [M+NH4]
+


































To a suspension of sodium hydride (60% dispersion in mineral oil, washed with 
hexane; 1.19 g, 29.7 mmol, 2.5 equiv.) in THF (30 mL) was added dimethyl carbonate 
(20 mL) and the reaction mixture was stirred at reflux whilst a solution of (+)-methyl 
(SS)-2-(N-(2,4,6-triisopropylphenylsulfonyl)phenylsulfonimidoyl)acetate (5.00 g, 11.9 
mmol, 1.0 equiv.) in THF (30 mL) was added dropwise. The stirred reaction was 
heated under reflux overnight, cooled in ice and quenched with mesylate 9 (2.49 g, 
11.9 mmol, 1.0 equiv.), followed by MeOH–AcOH (2:1; 10 mL) The solution was 
poured on to water and the product extracted with Et2O (×5). The combined organic 
39 
layers were washed with sat. aq. NaHCO3 and H2O, dried (MgSO4) and concentrated 
under reduced pressure. The yellow oil was purified by chromatography (100% 
CH2Cl2) to give recovered (+)-methyl (SS)-2-(N-(2,4,6-
triisopropylphenylsulfonyl)phenylsulfonimidoyl)acetate (2.06 g, 36%) as a colourless 
solid, and methyl (SS,Z)-6-(methoxymethoxy)-2-(N-(2,4,6-triisopropylphenyl-
sulfonyl)phenylsulfonimidoyl)hex-4-enoate (3.01 g, 47%) as a yellow oil; Rf  0.17 
(100% CH2Cl2); max (film) 2958, 1747, 1600, 1448, 1362, 1317, 1244, 1196, 1150, 
1094, 1048, 998, 940, 922, 844, 768, 749, 685, 665 cm
-1
; H (400 MHz) 7.95 (2H, d, J 
8.0 Hz, o-Ph), 7.73 (1H, tt, J 7.5, 1.0 Hz, p-Ph), 7.59 (2H, td, J 8.0, 3.0 Hz, m-Ph), 
7.13 (2H, s, m-SO2Ar), 5.70 (1H, dt, J 11.0, 6.5 Hz, OCH2CH), 5.39 (1H, dd, J 11.0, 
7.0 Hz, SCHCH2CH), [4.57, 4.56] (2H, 2 × s, CH2OCH3), 4.06–3.95, (2H, m, o-
ArCH), [3.72, 3.62] (3H, 2 × s, CO2CH3), [3.32, 3.31] (3H, 2 × s, CH2OCH3), 2.88 
(1H, sept, J 7.0 Hz, p-ArCH), 1.28–1.19 (18H, m, CH(CH3)2); C (100 MHz) 165.3, 
165.1 (C=O), 152.2, 152.1, 149.2, 149.1, 137.3, 137.0, 134.2, 132.3, 131.1, 124.9 
(4°), 134.9, 134.8, 132.6, 131.2, 129.8, 129.2, 124.9, 123.5 (3°), 95.8 (OCH2O), 71.4, 
70.7 (SCH), 62.6, 62.6 (OCH2OCH2), 55.4, 55.3 (CH2OCH3), 53.3, 53.2 (CO2CH3), 
34.1, (p-ArCH), 29.3, 29.3 (o-ArCH), 26.5, 25.2 (SCHCH2), 24.7, 24.6 (o-
ArCH(CH3)2), 23.6, (p-ArCH(CH3)2); m/z (CI) 611 [M+NH4]
+
, 567, 532, 497, 425, 
301 (Found [M+NH4]
+
, 611.2388. C30H43NO7S2 requires [M+NH4]
+
, 611.2825) 















According to general procedure E, a solution of methyl (SS,Z)-6-(methoxymethoxy)-
2-(N-(2,4,6-triisopropylphenylsulfonyl)phenylsulfonimidoyl)hex-4-enoate (2.50 mg, 
4.20 mmol) in MeCN (42 mL) was treated with 2 M aq. HCl (8.5 mL) to give methyl 
(SS,Z)-6-hydroxy-2-(N-(2,4,6-triisopropylphenylsulfonyl)phenylsulfonimidoyl)hex-4-
enoate (2.14 g, 93%) as a yellow oil; Rf 0.24 (50% EtOAc–petrol); max (film) 3425, 
2960, 1743, 1643, 1600, 1448, 1314, 1245, 1149, 1093, 1054 cm
-1
; H (400 MHz) 
7.95 (2H, d, J 8.0 Hz, o-Ph), 7.76 (1H, dt, J 7.5, 7.5 Hz, p-Ph), 7.62 (2H, dt, J 8.0, 7.5 
40 
Hz, m-Ph), 7.14 (2H, s, m-SO2Ar), 5.79 (1H, dt, J 13.0, 6.5 Hz, CHCH2OH), 5.37 
(1H, dt, J 18.0, 8.0 Hz, SCHCH2CH), [4.99, 4.59] (1H, 2 × dd, J 11.5, 3.5 Hz, SCH), 
4.37 (2H, 2 × sept, J 6.5 Hz, o-ArCH), 4.18–4.06 (2H, m, CH2OH), [3.77, 3.63] (3H, 
2 × s, OCH3), 3.00–2.87 (2H, m, p-ArCH and 1 × SCHCH2), [2.80–2.71, 2.59–2.51] 
(1H, 2 × m, 1 × SCHCH2), 1.30–1.18 (18H, m, CH(CH3)2); C (100 MHz) 165.8, 
165.5 (C=O), 152.3, 152.1, 149.2, 149.1, 137.9, 137.2, 136.9, 134.9, 133.8, 128.2, 
124.0 (4°), 135.0, 133.8, 129.7, 129.7, 129.2, 129.1, 125.3, 124.7, 123.5, 123.5 (3°), 
71.5, 70.8 (SCH), 58.1, 58.0 (CH2OH), 53.4, 53.3 (CO2CH3), 34.1, (p-ArCH), 29.4, 
29.3 (o-ArCH), 26.4, 25.1 (SCHCH2), 24.7, 24.6 (o-ArCH(CH3)2), 23.6, (p-
ArCH(CH3)2); m/z (CI) 567 [M+NH4]
+
, 425, 301, 284, 194 (Found [M+NH4]
+
, 

















According to general procedure F, a solution of methyl (SS,Z)-6-hydroxy-2-(N-(2,4,6-
triisopropylphenylsulfonyl)phenylsulfonimidoyl)hex-4-enoate (2.14 g, 3.89 mmol, 1.0 
equiv.) in THF (10 mL) was treated with 2 M aq. LiOH (10.0 mL, 20.0 mmol, 5.0 
equiv.) to give (SS,Z)-6-hydroxy-2-(N-(2,4,6-triisopropylphenylsulfonyl)phenylsulfon-
imidoyl)hex-4-enoic acid (1.84 g, 88%) as a colourless crystalline solid; mp 58–60 
°C; max (film) 3445 (br), 2963, 1645, 1600, 1448, 1265, 1147, 1094, 1063, 738 cm
-1
; 
H (400 MHz) 7.95, (2H, d, J 7.5 Hz, o-Ph), 7.73 (1H, m, p-Ph), 7.59 (2H, dt, J 7.5, 
7.5 Hz, m-Ph), 7.13 (2H, s, m-SO2Ar), 5.76 (1H, dd, J 17.5, 7.0 Hz, CHCH2OH), 5.58 
(1H, br s, CO2H), 5.42 (1H, dd, J 16.0, 10.0 Hz, SCHCH2CH), [4.83, 4.58] (1H, 2 × 
dd, J 11.5, 3.0 Hz, SCH), 4.32 (2H, sept, J 6.5 Hz, o-ArCH), [4.12, 4.01] (2H, 2 × d, J 
6.5 Hz, CH2OH), 2.95–2.56 (3H, m, p-ArCH and SCHCH2), 1.29–1.20 (18H, m, 
CH(CH3)2); C (100 MHz) 166.7, 166.2 (C=O), 152.4, 149.2, 136.8, 134.3, 133.9, 
124.2 (4°), 135.0, 133.0, 132.8, 129.7, 129.3, 124.9, 124.7, 123.5 (3°), 71.4, 70.9 
(SCH), 58.5, 57.8 (CH2OH), 34.2 (p-ArCH), 29.3 (o-ArCH), 26.2, 25.1 (SCHCH2), 
24.7, 24.7, 24.6, 24.6 (o-ArCH(CH3)2), 23.6 (p-ArCH(CH3)2); m/z (FAB) 536 
[M+NH4]
+






, 536.2141) (Found: C, 60.55; H, 6.91; N, 2.63. 

















According to general procedure G, a solution of (SS,Z)-6-hydroxy-2-(N-(2,4,6-
triisopropylphenylsulfonyl)phenylsulfonimidoyl)hex-4-enoic acid (1.00 g, 1.87 mmol, 
1.0 equiv.) in CH2Cl2 (10 mL) was treated with EDCI (0.39 g, 2.05 mmol, 1.1 equiv.) 
and purified by chromatography (50% EtOAc–petrol) to give (SS)-3-(N-(2,4,6-
triisopropylphenylsulfonyl)phenylsulfonimidoyl)-4,7-dihydrooxepin-2(3H)-one 20 
(0.87 g, 90%) as a colourless crystalline solid; mp 77–79 °C; Rf 0.63 (50% EtOAc–
petrol);  max (film) 3442 (br), 3055, 1752, 1638, 1600, 1422, 1265, 1148, 1093, 1054, 
895, 735 cm
-1
; H (500 MHz) 8.14 (2H, 2 × dt, J 7.0, 1.5 Hz, o-Ph), 7.69 (1H, m, p-
Ph), 7.57 (2H, m, m-Ph), [7.11, 7.10] (2H, 2 × s, m-SO2Ar), [6.00, 5.73] (1H, dd, J 
13.0, 3.5Hz, SCH), 5.88 (2H, br d, J 3.5 Hz, HC=CH), [5.12, 4.51] (2H, m, OCH2), 
4.37 (2H, sept, o-ArCH), [3.40, 3.21] (1H, dd, J 17.5, 3.0 Hz, SCHCH2), 2.87 (1H, 
sept, p-ArCH), 2.41 (1H, td, J 16.0, 2.5 Hz, SCHCH2), 1.27–1.14 (18H, m, 
CH(CH3)2); C (125 MHz) 166.3 (C=O), 152.2, 149.2, 149.0, 137.0, 136.7, 133.5, 
133.1 (4°), 134.8, 134.8, 131.1, 130.9, 128.8, 128.7, 124.8, 124.4, 123.5, 123.4 (3°), 
66.0, 65.8 (SCH), 64.2, 64.0 (OCH2), 34.1 (p-ArCH), 29.3, 29.2 (o-ArCH), 28.9, 27.6 
(SCHCH2), 24.7, 24.7, 24.6, 24.5 (o-ArCH(CH3)2), 23.6 (p-ArCH(CH3)2); m/z (CI) 
535 [M+NH4]
+
, 491, 425, 301 (Found [M+NH4]
+
, 535.2300. C27H35NO5S2 requires 
[M+NH4]
+
, 535.2300) (Found: C, 62.54; H, 6.71; N, 2.87. C27H35NO5S2 requires C, 





















According to general procedure H, a solution of lactone 20 (50.0 mg, 97.0 μmol, 1.0 
equiv.) was treated with BSA (23.9 l, 97.0 μmol, 1.0 equiv.) and KOAc (1.0 mg, 
9.70 μmol, 0.1 equiv.) in DMF (1 mL) to give a diastereomeric mixture (3:2, 
unassigned) of (SS,1R,2S)-S-phenyl-S-(2-vinylcyclopropyl)-N-tosylsulfoximine and 
(SS,1S,2R)-S-phenyl-S-(2-vinylcyclopropyl)-N-tosylsulfoximine 22 (32 mg, 69%) as a 
brown oil; Rf 0.80 (50% EtOAc–petrol); max (film) 3449 (br), 3057, 1639, 1421, 
1264, 1148, 1100, 895, 737 cm
-1
; H (500 MHz) 7.94 (2H, dt, J 8.0, 1.5 Hz, o-Ph), 
7.66 (1H, m, p-Ph), 7.56 (2H, td, J 8.0, 1.5 Hz, m-Ph), 7.11 (1H, s, m-SO2Ar major), 
7.10 (1H, s, m-SO2Ar minor), 5.50 (1H, ddd, J 17.0, 10.0, 7.5 Hz, CH=CH2 minor), 
5.32 (1H, ddd, J 17.0, 10.0, 7.5 Hz, CH=CH2 major), 5.23 (1H, d, J 17.0 Hz, CH=CH2 
cis minor), 5.11 (1H, d, J 10.0 Hz, CH=CH2 trans minor), 5.04 (1H, d, J 17.0 Hz, 
CH=CH2 cis major), 4.98 (1H, d, J 10.0 Hz, CH=CH2 trans major), 4.35 (2H, 2 × 
sept, J 7.0 Hz, o-ArCH), 2.88 (1H, sept, J 7.0 Hz, p-ArCH), 2.67 (1H, m, SCH 
major), 2.65 (1H, m, SCH minor), 2.61 (1H, m, SCHCH minor), 2.23 (1H, m, 
SCHCH major), [1.92, 1.37] (2H, 2 × m, SCHCH2 major), [1.50, 1.10] (2H, 2 × m, 
SCHCH2 minor), 1.28–1.20 (18H, m, CH(CH3)2); C (125 MHz) 151.9, 151.8, 149.1, 
139.2, 139.2, 137.3 (4°), 134.3, 133.9, 129.4, 127.7, 127.6, 123.3 (3°), 134.2, 133.8 
(CH=CH2), 117.5, 117.2 (CH=CH2), 42.0 (SCH), 34.1 (p-ArCH), 29.2, 29.2 (o-
ArCH), 24.7, 24.7, 24.6, 24.6 (o-ArCH(CH3)2), 23.7, 23.2 (SCHCH), 23.6 (p-




, 301, 52 
(Found [M+H]
+
, 474.2157. C26H35NO3S2 requires [M+H]
+
, 474.2137) (Found: C, 
66.00; H, 7.44; N, 2.80. C26H35NO3S2 requires C, 65.92; H, 7.45; N, 2.96). 
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According to general procedure D, a suspension of sodium hydride (13.7 mg, 0.57 
mmol, 1.2 equiv.) in THF (0.75 mL) was treated with (±)-methyl 2-(N-(2,4,6-
triisopropylphenylsulfonyl)phenylsulfonimidoyl)acetate (228 mg, 0.48 mmol, 1.0 
equiv.) in THF (1.0 mL) and methanesulfonic acid (Z)-4-methoxymethoxy-2-
phenylbut-2-enyl ester (136 mg, 0.48 mmol, 1.0 equiv.) in THF (0.75 mL) to give (±)-
methyl (Z)-6-methoxymethoxy-4-phenyl-2-(N-(2,4,6-triisopropylphenylsul-
fonyl)phenylsulfonimidoyl)hex-4-enoate, which was used without further purification; 




















According to general procedure E, a solution of (Z)-6-methoxymethoxy-4-phenyl-2-
(N-(2,4,6-triisopropylphenylsulfonyl)phenylsulfonimidoyl)hex-4-enoate (276 mg, 
0.41 mmol, 1.0 equiv.) in MeCN (4 mL) was treated with 2 M aq. HCl (0.8 mL). 
Purification by chromatography (20→50% EtOAc–petrol) gave (±)-methyl (Z)-6-
hydroxy-4-phenyl-2-(N-(2,4,6-triisopropylphenylsulfonyl)phenylsulfonimidoyl)hex-
4-enoate as a colourless oil; Rf 0.16 (50% EtOAc–petrol); max (film) 2957, 2869, 
1743, 1599, 1447, 1313, 1296, 1243, 1195, 1147, 1091, 1048, 1021, 997, 764, 683 
cm
-1
; H (400 MHz) 7.93 (2H, dd, J 8.0, 8.0 Hz, o-SPh), 7.74 (1H, m, p-SPh), 7.59 
(2H, m, m-SPh), 7.32–7.17 (5H, m, Ph), 7.10 (2H, s, m-SO2Ar), 5.97 (1H, 2 × t, J 6.5 
Hz, CHCH2OH), [4.63, 4.41] (1H, 2 × dd, J 11.5, 3.5 Hz, SCH), 4.30 (2H, sept, J 7.0 
Hz, o-ArCH), 4.20 (2H, m, CH2OH), [3.48, 3.41] (3H, 2 × s, OCH3), 3.17 (2H, m, 
SCHCH2), 2.87 (1H, 2 × sept, J 7.0 Hz, p-ArCH), [2.04, 1.84] (1H, 2 × dd, J 7.0, 5.0 
44 
Hz, SCHCH2), 1.27–1.18 (18H, m, CH(CH3)2); C (100 MHz) 165.5, 165.4 (C=O), 
152.2, 152.1, 149.2, 149.1, 139.4, 139.3, 137.1, 137.0, 134.8, 134.6, (4°), 136.1, 
135.8, 135.2, 134.9, 129.7, 129.6, 129.2, 128.8, 128.6, 128.2, 128.1, 126.6, 126.4 (3°), 
123.4, 123.4 (m-SO2Ar), 70.6, 70.4 (SCH), 58.9, 58.8 (CH2OH), 53.1, 53.1 (OCH3), 
34.1 (p-ArCH), 29.3 (o-ArCH), 27.8, 26.7, (SCHCH2), 24.7, 24.6 (o-ArCH(CH3)2), 







, 643.2870) (Found: C, 65.29; H, 6.93; N, 2.24. 




















According to general procedure F, a solution of (±)-methyl (Z)-6-hydroxy-4-phenyl-
2-(N-(2,4,6-triisopropylphenylsulfonyl)phenylsulfonimidoyl)hex-4-enoate (117 mg, 
0.19 mmol, 1.0 equiv.) in THF (0.5 mL) was treated with 2 M aq. LiOH (0.5 mL) to 
give (±)-(Z)-6-hydroxy-4-phenyl-2-(N-(2,4,6-triisopropylphenylsulfonyl)phenylsul-
fonimidoyl)hex-4-enoic acid as a colourless foam, which was used without further 
purification; max (film) 3420, 2959, 1738, 1599, 1447, 1311, 1295, 1244, 1147, 1092, 
1049, 1021, 997, 764, 753, 743, 684 cm
-1
; H (300 MHz; CD3OD) 7.87 (2H, d, J 8.0 
Hz, o-SPh), 7.79 (1H, 2 × t, J 7.5 Hz, p-SPh), 7.61 (2H, 2 × t, J 8.0 Hz, m-SPh), 7.31 
(2H, s, m-SO2Ar), 7.25–7.09 (5H, m, Ph), [5.93, 5.87] (1H, 2 × t, J 6.5 Hz, 
CHCH2OH), 4.20 (2H, 2 × sept, J 6.5 Hz, o-ArCH), 4.29–4.04 (3H, m, SCH and 
CH2OH), 3.40–3.06 (2H, m, SCHCH2), 2.90 (1H, 2 × sept, J 6.5 Hz, p-ArCH), 1.26–
1.12 (18H, m, CH(CH3)2); C (75 MHz; CD3OD) 166.7, 166.6 (C=O), 153.8, 153.8, 
150.6, 150.6, 141.2, 141.0, 138.5, 138.5, 136.2, 136.1, 133.4, 133.3 (4°),  136.5, 
136.4, 130.9, 130.9, 130.6, 130.4, 129.8, 129.7 129.1, 129.1, 127.7, 127.6, 124.6 (3°), 
72.0, 71.5 (SCH), 59.7, 59.7 (CH2OH), 35.4 (p-ArCH), 30.5, 30.5 (o-ArCH), 28.6, 
28.0 (SCHCH2), 25.1, 25.1 (o-ArCH(CH3)2), 24.1 (p-ArCH(CH3)2); m/z (CI) 629 
[M+NH4]
+
, 594, 550 (Found [M+NH4]
+






















According to general procedure G, a solution of (±)-(Z)-6-hydroxy-4-phenyl-2-(N-
(2,4,6-triisopropylphenylsulfonyl)phenylsulfonimidoyl)hex-4-enoic acid (109 mg, 
0.18 mmol, 1.0 equiv.) in CH2Cl2 (1.0 mL) was treated with EDCI (41 mg, 0.21 
mmol, 1.2 equiv.). Purification by chromatography (30% EtOAc–petrol) gave (±)-5-
phenyl-3-(N-(2,4,6-triisopropylphenylsulfonyl)phenylsulfonimidoyl)-4,7-dihydro-
oxepin-2(3H)-one 23a (103 mg, 36% over four steps) as a colourless solid; Rf 0.45 
(50% EtOAc–petrol); max (film) 2958, 1753, 1599, 1446, 1311, 1246, 1148, 1093, 
1057 cm
-1
; H (400 MHz) 8.17 (2H, m, o-SPh), 7.70 (1H, td, J 7.5, 1.5 Hz, p-SPh), 
7.58 (2H, m, m-SPh), 7.37–7.31 (4H, m, o-/m-Ph), 7.27 (1H, m, p-Ph), [7.12, 7.11] 
(2H, 2 × s, m-SO2Ar), [6.15, 5.91] (1H, dd, J 13.0, 3.5 Hz, SCH), 6.05 (1H, ddtd, J 
9.5, 5.5, 3.5, 2.0 Hz, OCH2CH), 5.26 (1H, ddd, J 16.0, 12.5, 3.5 Hz, OCH2), 4.67 (1H, 
dd, J 16.0, 7.5 Hz, OCH2), 4.39 (2H, 2 × sept, J 7.0 Hz, o-ArCH), [3.82, 3.61] (1H, d, 
J 17.5 Hz, SCHCH2), 2.87 (1H, 2 × sept, J 7.0 Hz, p-ArCH), 2.75 (1H, 2 × d, J 13.5 
Hz, SCHCH2), 1.28–1.20 (18H, m, CH(CH3)2); C (100 MHz) 166.3 (C=O), 152.3, 
149.3, 149.0, 141.0, 140.8, 140.4, 140.3, 137.0, 136.6, 133.6, 133.2 (4°), 134.9, 131.1, 
131.0, 128.9, 128.8, 128.7, 128.7, 126.3, 126.0, 123.5, 123.5, 121.9, 121.6 (3°), 66.0, 
65.7 (SCH), 64.4, 64.2 (OCH2), 34.1 (p-ArCH), 31.9, 30.4 (SCHCH2), 29.4, 29.3 (o-
ArCH), 24.7, 24.7, 24.6, 24.5 (o-ArCH(CH3)2), 23.6 (p-ArCH(CH3)2); m/z (CI) 611 
[M+NH4]
+
, 425, 301, 251, 206, 156, 132 (Found [M+NH4]
+
, 611.2623. C33H39NO5S2 
requires [M+NH4]
+
, 611.2613) (Found: C, 66.66; H, 6.53; N, 2.27. C33H39NO5S2 









































According to general procedure H, a solution of lactone 23a (50 mg, 0.08 mmol, 1.0 
equiv.) in DMF (0.4 mL) was treated with KOAc (0.8 mg, 0.008 mmol, 0.1 equiv.) 
and BSA (20.8 μL, 0.08 mmol, 1.0 equiv.) to give the sulfoximines 24a–27a as a 
colourless gum (34 mg, 78%) as a mixture of diastereomers (ratio 24a:25a:26a:27a = 
44:22:26:7) which were separable by chromatography (10% EtOAc–petrol); 25a 
(isolated as a single diastereoisomer): Rf 0.44 (50% EtOAc–petrol); max (film) 2960, 
1600, 1447, 1423, 1311, 1265, 1148, 1099, 1068, 998, 737, 702 cm
-1
; H (400 Hz) 
8.03 (2H, d, J 7.5 Hz, o-Ph), 7.70 (1H, tt, J 7.5, 1.5 Hz, p-Ph), 7.60 (2H, t, J 7.5 Hz, 
m-Ph), 7.21 (3H, m, Ph), 7.11 (2H, s, m-SO2Ar), 6.82 (2H, m, Ph), 6.12 (1H, dd, J 
17.0, 10.5 Hz, CH=CH2), 5.04 (1H, dd, J 10.5, 1.0 Hz, CH=CH2 trans), 4.42 (1H, d, J 
17.0 Hz, CH=CH2 cis), 4.39 (2H, sept, J 7.0 Hz, o-ArCH), 3.33 (1H, dd, J 9.0, 6.0 Hz, 
SCH), 2.88 (1H, sept, J 7.0 Hz, p-ArCH), 2.30 (1H, dd, J 6.0, 6.0 Hz, SCHCH2), 2.07 
(1H, dd, J 9.0, 6.0 Hz, SCHCH2), 1.24 (18H, m, CH3);C (100 MHz) 151.9, 149.1, 
139.2, 139.1, 137.3 (4°), 138.8 (CH=CH2), 134.0, 129.2, 128.6, 127.8, 127.7, 123.3 
(3°), 119.0 (CH=CH2), 48.4 (SCH), 39.4 (SCHC), 34.1 (p-ArCH), 29.2 (o-ArCH), 
24.7, 24.6, 23.7, 23.6 (CH(CH3)2), 20.0 (SCHCH2); m/z (CI) 550 [M+H]
+
, 567, 425, 
301 (Found [M+H]
+
, 550.2457. C32H39NO3S2 requires [M+H]
+
, 550.2450); 24a 
(isolated as a single diastereoisomer): Rf 0.41 (50% EtOAc–petrol); max (film) 2961, 
2929, 1600, 1463, 1447, 1423, 1311, 1265, 1149, 1097, 1051, 739, 703 cm
-1
; H (400 
Hz) 8.04 (2H, d, J 7.5 Hz, o-Ph), 7.68 (1H, t, J 7.5 Hz, p-Ph), 7.58 (2H, t, J 7.5 Hz, m-
47 
Ph), 7.29 (5H, m, Ph), 7.12 (2H, s, m-SO2Ar), 6.43 (1H, dd, J 17.0, 10.5 Hz, 
CH=CH2), 5.12 (1H, d, J 10.5 Hz, CH=CH2 trans), 4.65 (1H, dd, J 17.0, 0.5 Hz, 
CH=CH2 cis), 4.39 (2H, sept, J 7.0 Hz, o-ArCH), 3.03 (1H, dd, J 8.5, 6.5 Hz, SCH), 
2.90 (1H, sept, J 7.0 Hz, p-ArCH), 2.03 (1H, dd, J 6.0, 6.0 Hz, SCHCH2), 1.75 (1H, 
dd, J 8.5, 6.0 Hz, SCHCH2), 1.28 (18H, m, CH3); C (125 MHz) 151.8, 149.2, 140.3, 
139.7, 137.5 (4°), 136.1, 133.8, 129.5, 129.4, 128.6, 127.9, 127.7, 123.2 (3°), 118.8 
(CH=CH2), 49.0 (SCH), 41.1 (SCHC), 34.1 (p-ArCH), 29.3 (o-ArCH), 24.8, 24.7, 
23.7, 23.6 (CH(CH3)2), 19.1 (SCHCH2); m/z (CI) 550 [M+H]
+
, 567, 425, 301 (Found 
[M+H]
+
, 550.2465. C32H39NO3S2 requires [M+H]
+
, 550.2450); 26a (isolated as a 
single diastereoisomer): Rf 0.38 (50% EtOAc–petrol); max (film) 2960, 2928, 1600, 
1463, 1448, 1311, 1295, 1265, 1244, 1148, 1098, 1068, 1030, 738, 702 cm
-1
; H (400 
Hz) 7.61 (1H, m, Ph), 7.43 (4H, m, Ph), 7.21 (1H, m, Ph), 7.10 (2H, m, Ph), 7.08 (2H, 
s, m-SO2Ar), 6.79 (2H, d, J 7.5 Hz, Ph), 5.72 (1H, dd, J 17.0, 10.5 Hz, CH=CH2), 
5.05 (1H, d, J 10.5 Hz, CH=CH2 trans), 4.82 (1H, d, J 17.0 Hz, CH=CH2 cis), 4.33 
(2H, sept, J 6.5 Hz, o-ArCH), 3.51 (1H, dd, J 9.0, 5.5 Hz, SCH), 2.87 (1H, sept, J 7.0 
Hz, p-ArCH), 2.63 (1H, dd, J 6.0, 6.0 Hz, SCHCH2), 1.89 (1H, dd, J 9.0, 6.0 Hz, 
SCHCH2), 1.25 (18H, m, CH3); C (100 MHz) 151.7, 149.0, 140.3, 137.8, 137.2 
(4°), 133.5, 132.4, 130.3, 129.4, 128.7, 128.0, 127.6, 123.2 (3°), 115.6 (CHCH2), 46.8 
(SCH), 38.2 (SCHC), 34.1 (p-ArCH), 29.1 (o-ArCH), 24.7, 24.6, 23.7, 23.6 
(CH(CH3)2), 17.4 (SCHCH2); m/z (CI) 550 [M+H]
+
, 567, 425, 301, 272, 254, 237 
(Found [M+H]
+
, 550.2435. C32H39NO3S2 requires [M+H]
+
























According to general procedure D, a suspension of sodium hydride (54 mg, 1.35 
mmol, 1.1 equiv.) in THF (1.5 mL) was treated with (±)-methyl 2-(N-(2,4,6-
triisopropylphenylsulfonyl)phenylsulfonimidoyl)acetate (589 mg, 1.23 mmol, 1.0 
equiv.) in THF (2 mL) and methanesulfonic acid (Z)-2-(2,4-difluorophenyl)-4-
(methoxymethoxy)but-2-enyl ester (396 mg, 1.23 mmol, 1.0 equiv.) in THF (1.5 mL) 
to give (±)-methyl (E)-4-(2,4-difluorophenyl)-6-(methoxymethoxy)-2-(N-(2,4,6-
48 
triisopropylphenylsulfonyl)phenylsulfonimidoyl)hex-4-enoate as a colourless gum, 
which was used without further purification; Rf 0.44 (50% EtOAc–petrol); max (film) 
2955, 2925, 1744, 1599, 1501, 1315, 1243, 1148, 1091, 1039, 1022, 997, 961, 845, 
684 cm
-1
; H (300 MHz) 7.92 (2H, d, J 7.5 Hz, o-Ph), 7.74 (1H, t, J 7.5 Hz, p-Ph), 
7.59 (2H, t, J 8.0 Hz, m-Ph), 7.08 (2H, m-SO2Ar), 7.13–7.03 (1H, m, ArF), 6.85–6.70 
(2H, m, ArF), 5.76 (1H, t, J 6.5 Hz, CHCH2O), 4.58 (2H, s, OCH2O), 4.47 (1H, dd, J 
12.0, 3.0 Hz, SCH), 4.27 (2H, sept, J 7.0 Hz, o-ArCH), 4.10 (2H, dd, J 6.5, 3.0 Hz, 
OCH2CH), 3.54 (3H, s, CO2CH3), 3.34 (3H, s, CH2OCH3), [3.21, 3.17] (1H, 2 × m, 
SCHCH2), 3.00 (1H, 2 × d, J 12.0 Hz, SCHCH2), 2.86 (1H, sept, J 7.0 Hz, p-ArCH), 
1.25–1.16 (18H, m, CH(CH3)2); C (75 MHz) 164.8 (C=O), 164.3, 164.0, 161.6, 
161.5, 161.0, 160.8, 158.3, 158.2 (CF), 152.1, 149.2, 137.0, 133.0 (4°),134.8, 134.7, 
129.7, 129.2, 123.4 (3°), 131.3, 131.2, 131.2, 131.1 (CFCHCH), 124.0, 123.9, 123.8, 
123.7 (CCF), 111.5, 111.5 111.3, 111.2 (CFCHCH), 104.6, 104.2, 103.9 (CFCHCF), 
95.9 (OCH2O), 70.1 (SCH), 63.3 (CHCH2O), 55.4 (CH2OCH3), 53.1 (CO2CH3), 34.1 
(p-ArCH), 29.7, 29.0 (SCHCH2), 29.3 (o-ArCH), 24.7 (o-ArCH(CH3)2), 23.6 (p-




, 723.2943. C36H45F2NO7S2 
requires [M+NH4]
+
, 723.2944) (Found: C, 61.23; H, 6.42; N, 1.95. C36H45F2NO7S2 




















According to general procedure E, (±)-methyl (E)-4-(2,4-difluorophenyl)-6-
(methoxymethoxy)-2-(N-(2,4,6-triisopropylphenylsulfonyl)phenylsulfonimidoyl)hex-
4-enoate (433 mg, 0.61 mmol, 1.0 equiv.) in MeCN (6 mL) was treated with 2 M aq. 
HCl (1.2 mL). Purification by chromatography (20→40% EtOAc–petrol) gave (±)-
methyl (E)-4-(2,4-difluorophenyl)-6-hydroxy-2-(N-(2,4,6-triisopropylphenylsul-
fonyl)phenylsulfonimidoyl)hex-4-enoate (331 mg, 41% over two steps) as a 
colourless gum; Rf 0.21 (50% EtOAc–petrol); max (film) 2958, 1743, 1599, 1501, 
1447, 1423, 1312, 1295, 1242, 1147, 1091, 1048, 1021, 997, 966, 846, 769, 740, 684 
cm
-1
; H (500 MHz) 7.90 (2H, m, o-Ph), 7.73 (1H, m, p-Ph), 7.58 (2H, m, m-Ph), 7.09 
49 
(1H, m, o-ArF), 7.09 (2H, s, m-SO2Ar), 6.79 (2H, m, m-ArF), 5.84 (1H, 2 × t, J 6.5 
Hz, CHCH2OH), [4.69, 4.38] (1H, 2 × dd, J 11.5, 3.5 Hz, CHCH2OH), 4.30 (2H, m, 
CH2OH), 4.24 (2H, m, o-ArCH), [3.53, 3.46] (3H, 2 × s, OCH3), [3.33, 3.25] (1H, 2 × 
dd, J 14.0, 3.5 Hz, SCHCH2), [3.16, 2.97] (1H, 2 × dd, J 14.0, 11.5 Hz, SCHCH2), 
2.86 (1H, 2 × sept, J 7.0 Hz, p-ArCH), [2.14, 1.85] (1H, t, J 6.0 Hz, OH), 1.21 (18H, 
m, CH(CH3)2); C (125 MHz) 165.6, 165.4 (C=O), 163.6, 163.5, 161.6, 161.5, 161.0, 
160.9, 159.0, 158.9 (CF), 152.2, 152.2, 149.2, 149.1, 137.1, 136.9, 134.0, 130.8, 
130.7 (4°), 124.1, 124.0, 124.0, 123.9 (CCF), 135.3, 135.1, 135.0, 134.9, 129.7, 129.6, 
129.2, 123.5, 123.4 (3°), 131.3, 131.3, 131.2, 131.2, 131.1, 131.1, 131.0, 131.0 
(CFCHCH), 111.7, 111.5, 111.3 (CFCHCH), 104.6, 104.4, 104.2, 104.0 (CFCHCF), 
70.7, 70.3 (SCH), 58.7, 58.5 (CH2OH), 53.2, 53.2 (OCH3), 34.1 (p-ArCH), 29.3, 29.3 
(o-ArCH), 28.9, 27.8 (SCHCH2), 24.7, 24.6 (o-ArCH(CH3)2), 23.6 (p-ArCH(CH3)2; F 
(376 MHz) [–108.8, –109.0] (1F, 2 × qd, J 8.0, 6.5 Hz, o-CF), –109.8 (1F, m, p-CF); 
m/z (EI) 679 [M+NH4]
+
, 644, 408 (Found [M+NH4]
+
, 679.2680. C34H41F2NO6S2 
requires [M+NH4]
+
, 679.2682) (Found: C, 61.80; H, 6.32; N, 2.18. C34H41F2NO6S2 




















According to general procedure F, a solution of (±)-methyl (E)-4-(2,4-
difluorophenyl)-6-hydroxy-2-(N-(2,4,6-triisopropylphenylsulfonyl)phenylsulfon-
imidoyl)hex-4-enoate (326 mg, 0.49 mmol, 1.0 equiv.) in THF (1.25 mL) was treated 
with 2 M aq. LiOH (1.25 mL) to give (±)-(E)-4-(2,4-difluorophenyl)-6-hydroxy-2-(N-
(2,4,6-triisopropylphenylsulfonyl)phenylsulfonimidoyl)hex-4-enoic acid (290 mg, 
91%) as a colourless foam, which was used without further purification; max (film) 
2958, 2556, 1731, 1599, 1501, 1448, 1423, 1293, 1244, 1141, 1091, 1049, 1021, 997, 
966, 848, 765, 741, 684 cm
-1
; H (300 MHz; CD3OD) 7.86 (2H, d, J 8.0 Hz, o-Ph), 
7.78 (1H, m, p-Ph), 7.60 (2H, m, m-Ph), 7.24–7.09 (1H, m, o-ArF), 7.15 (2H, s, m-
SO2Ar), 6.96–6.81 (2H, m, m-ArF), 5.77 (1H, 2 × t, J 6.5 Hz, CHCH2OH), 4.29–4.03 
(3H, m, SCH and CH2OH), 4.17 (2H, 2 × sept, J 6.5 Hz, o-ArCH), 3.28–3.05 (2H, m, 
50 
SCHCH2), 2.90 (1H, 2 × sept, J 7.0 Hz, p-ArCH), 1.26–1.12 (18H, m, CH(CH3)2); C 
(75 MHz; CD3OD) 166.0 (C=O), 165.9, 165.7, 163.2, 163.0, 162.6, 162.4, 159.9, 
159.7 (CF), 153.8, 150.6, 150.6, 138.5, 138.4, 137.2, 137.0, 136.3, 136.2 (4°), 126.0, 
126.0, 125.8, 125.6 (CCF), 133.2, 133.1, 133.0, 133.0, 131.5, 131.4, 124.5 (3°), 130.9, 
130.8, 130.6, 130.4 (CFCHCH), 112.7, 112.4, 112.3 (CFCHCH), 105.4, 105.0, 104.7 
(CFCHCF) 72.0, 71.4 (SCH), 59.3, 59.2 (CH2OH), 35.4 (p-ArCH), 30.5 (o-ArCH), 
29.7, 29.0 (SCHCH2) 25.1, 25.1, 25.0 (o-ArCH(CH3)2), 24.1 (p-ArCH(CH3)2); m/z 
(EI) 665 [M+NH4]
+
, 630 (Found [M+NH4]
+
, 665.2524. C33H39F2NO6S2 requires 
[M+NH4]
+
, 665.2525) (Found: C, 61.06; H, 5.99; N, 2.09. C33H39F2NO6S2 requires C, 



















F 23b  
According to general procedure G, (±)-(E)-4-(2,4-difluorophenyl)-6-hydroxy-2-(N-
(2,4,6-triisopropylphenylsulfonyl)phenylsulfonimidoyl)hex-4-enoic acid (260 mg, 
0.40 mmol, 1.0 equiv.) in CH2Cl2 (1.0 mL) at 0 °C was treated with EDCI (85 mg, 
0.44 mmol, 1.1 equiv.). Purification by chromatography (40% EtOAc–petrol) gave 
(±)-5-(2,4-difluorophenyl)-3-(N-(2,4,6-triisopropylphenylsulfonyl)phenylsulfon-
imidoyl)-4,7-dihydrooxepin-2(3H)-one 23b (89 mg, 35%) as a colourless solid; mp 
86–87 °C; Rf 0.48 (50% EtOAc–petrol); max (film) 2959, 1754, 1502, 1231, 1141, 
1090, 1048, 1022, 998, 972, 847, 733, 682 cm
-1
; H (400 MHz) 8.13 (2H, 2 × d, J 7.0 
Hz, o-Ph), 7.70 (1H, t, J 7.5 Hz, p-Ph), 7.57 (2H, t, J 7.5 Hz, m-Ph), 7.30–7.12 (1H, 
m, o-ArF), [7.12, 7.10] (2H, 2 × s, m-SO2Ar), 6.92–6.79 (2H, m, m-ArF), [6.08, 5.89] 
(1H, 2 × dd, J 13.0, 3.5 Hz, SCH), 5.96 (1H, m, CHCH2O), 5.23 (1H, ddd, J 16.0, 
13.0, 3.5 Hz, OCH2), 4.68 (1H, ddd, J 16.0, 7.5, 4.0 Hz, OCH2), 4.37 (2H, sept, J 6.5 
Hz, o-ArCH), [3.66, 3.47] (1H, 2 × d, J 17.5 Hz, SCHCH2), 2.88 (1H, sept, J 6.5 Hz, 
p-ArCH), 2.78 (1H, m, SCHCH2) 1.27–1.12 (18H, m, CH(CH3)2); C (125 MHz) 
166.1, 166.0 (C=O), 163.8, 163.8, 161.9, 161.8, 160.6, 160.5, 158.6, 158.5 (CF), 
51 
152.3, 152.2, 149.2, 149.0, 136.9, 136.5, 135.9, 135.7, 134.9, 134.9, 133.5, 133.2 (4°), 
131.0, 130.9, 128.9, 128.8, 125.5, 125.1, 123.5, 123.4 (3°), 130.6, 130.6, 130.5, 130.5, 
130.4, 130.4, 130.3, 130.3 (CFCHCH), 124.7, 124.7, 124.6, 124.5 (CCF), 111.9, 
111.8, 111.8, 111.8 111.7, 111.7, 111.6, 111.6 (CFCHCH), 104.7, 104.5, 104.3 
(CFCHCF), 65.8, 65.4 (SCH), 64.0, 63.8 (OCH2), 34.1, 34.1 (p-ArCH), 32.0, 30.6 
(SCHCH2), 29.3, 29.3 (o-ArCH), 24.7, 24.6, 24.4 (o-ArCH(CH3)2), 23.6 (p-









, 630.2154) (Found: C, 63.07; H, 5.97; N, 2.18. 













































According to general procedure H, lactone 23b (7.0 mg, 0.02 mmol, 1.0 equiv.) in 
DMF (0.1 mL) was treated with KOAc (pinch) and BSA (4.6 μL, 0.02 mmol, 1.0 
equiv.) to give the sulfoximines 24b–27b as a colourless gum (5 mg, 70%) as a 
mixture of diastereoisomers (ratio 24b:25b:26b:27b = 44:16:33:7) which were 
partially separable by chromatography (10→40% EtOAc–petrol); 25b (isolated as a 
single diastereoisomer): Rf 0.60 (50% EtOAc–petrol); max (film) 2985, 1740, 1447, 
1374, 1240, 1047, 938, 847, 737, 634, 608 cm
–1
; H (500 MHz) 8.00 (2H, dd, J 8.5, 
52 
1.0 Hz, o-Ph), 7.69 (1H, tt, J 7.5, 1.5 Hz, p-Ph), 7.57 (2H, t, J 8.0 Hz, m-Ph), 7.12 
(2H, s, m-SO2Ar), 6.89 (1H, dt, J 8.5, 6.5 Hz, CFCHCH) 6.78 (1H, t, J 8.0, Hz, 
CFCHCH) 6.67 (1H, ddd, J 10.0, 9.0, 2.5 Hz, CFCHCF) 6.11 (1H, dd, J 17.0, 10.5 
Hz, CH=CH2), 5.06 (1H, dd, J 10.5, 1.0 Hz, CH=CH2 trans) 4.44 (1H, d, J 17.0 Hz, 
CH=CH2 cis) 4.40 (2H, sept, J 7.0 Hz, o-ArCH) 3.29 (1H, dd, J 9.0, 6.0 Hz, SCH) 
2.88 (1H, sept, J 7.0 Hz, p-ArCH) 2.39 (1H, dd, J 6.5, 6.5 Hz, SCHCH2) 2.06 (1H, dd, 
J 9.0, 6.5 Hz, SCHCH2), 1.22–1.25 (18H, m, CH(CH3)2);C (125 MHz) 163.6, 163.5, 
162.3, 162.2, 160.2, 160.1 (CF), 152.0, 149.1, 138.2, 137.1 (4°), 134.2 (CH=CH2), 
134.1 (p-Ph), 132.0, 131.9, 131.9 (CFCHCH), 129.0 (m-Ph), 128.1 (o-Ph), 123.3 (m-
SO2Ar), 122.3, 122.2 (CCF), 118.4 (CH=CH2), 111.7, 111.6 (CFCHCH), 104.5, 
104.3, 104.1 (CFCHCF), 48.0 (SCH), 34.1 (SCHC), 34.1 (p-ArCH), 29.2 (o-ArCH), 
24.7, 24.6, 23.7, 23.6 (CH(CH3)2), 20.3 (SCHCH2); m/z (CI) 603 [M+NH4]
+
, 586, 301 
(Found [M+H]
+
, 586.2257. requires [M+H]
+
, 586.2261); 24b and 26b (isolated as a 
mixture of the two diastereoisomers): Rf 0.67 (50% EtOAc–petrol); max (film) 2985, 
1740, 1447, 1374, 1240, 1094, 1047, 938, 847, 737, 634, 608 cm
–1
; H (500 MHz) 
8.03 (2H, dd, J 8.5, 1.0 Hz, o-Ph 24b ) 7.66 (2H, m, Ph) 7.57 (3H, m, Ph) 7.47 (2H, 
dd, J 8.5, 7.5 Hz, m-Ph minor) 7.32 (1H, dt, J 8.5, 6.5 Hz, p-Ph 24b ), 7.11 (2H, s, m-
SO2Ar 24b ), 7.06 (2H, s, m-SO2Ar 26b), 6.85 (1H, m, ArF), 6.74 (1H, m, ArF), 6.50 
(1H, m, ArF), 6.36 (1H, dd, J 17.0, 10.5 Hz, CH=CH2 24b ), 5.60 (1H, dd, J 17.0, 
10.5 Hz, CH=CH2 26b), 5.11 (1H, dd, J 10.5, 1.0 Hz, CH=CH2 trans 24b ), 5.02 (1H, 
d, J 10.5Hz, CH=CH2 trans 26b), 4.74 (1H, dd, J 17.0, 1.5 Hz, CH=CH2 cis 26b), 
4.64 (1H, d, J 17.0Hz, CH=CH2 cis 24b ), 4.35 (2H, sept, J 6.5 Hz, o-ArCH 24b ), 
4.27 (2H, sept, J 6.5 Hz, o-ArCH 26b), 3.43 (1H, dd, J 9.0, 5.5 Hz, SCH 26b), 2.98 
(1H, dd, J 9.0, 6.5 Hz, SCH 24b ), 2.88 (1H, sept, J 6.5 Hz, p-ArCH 24b ), 2.85 (1H, 
sept, J 6.5 Hz, p-ArCH 26b), 2.61 (1H, dd, J 6.0, 6.0 Hz, SCHCH2 26b), 2.13 (1H, 
dd, J 6.5 Hz, SCHCH2 24b ), 1.96 (1H, dd, J 9.0, 6.5 Hz, SCHCH2 26b), 1.71 (1H, 
dd, J 9.0, 6.0 Hz, SCHCH2 24b ), 1.30–1.17 (18H, m, CH(CH3)2);C (125 MHz) 
163.7, 163.6, 163.5, 162.8, 162.1, 162.1, 161.7, 161.6, 161.5, 160.8, 160.7, 160.1, 
160.0 (CF), 151.9, 149.2, 149.0, 137.6, 137.4, 137.0 (4°), 138.5, 134.5 (CH=CH2), 
134.0, 133.9, 129.4, 129.0, 128.0, 127.6 (3°), 132.9, 132.9, 132.8, 132.8 (CFCHCH), 
123.3, 122.8, 122.8, 122.7, 122.6 (CCF), 118.3, 115.6 (CH=CH2), 117.0, 117.0, 
111.7, 111.7, 111.5, 111.5, 111.2, 111.0 (CFCHCH), 104.4, 104.2, 104.1, 104.0, 
103.9, 103.7 (CFCHCF), 48.9, 46.7 (SCH), 35.5, 34.1, 33.9 (p-ArCH), 29.7, 29.3, 
29.1 (o-ArCH), 24.8, 24.8, 24.6, 24.6, 23.7, 23.6, 23.6 (CH(CH3)2), 19.7, 17.7 
53 
(SCHCH2); m/z (CI) 603 [M+NH4]
+
, 586, 425 (Found [M+H]
+



























According to general procedure D, sodium hydride (102 mg, 2.55 mmol, 1.2 equiv.) 
in DMF (3.5 mL) was treated with (±)-methyl 2-(N-(2,4,6-
triisopropylphenylsulfonyl)phenylsulfonimidoyl)acetate (1.02 g, 2.13 mmol, 1.0 
equiv.) in DMF (3.5 mL) and methanesulfonic acid (Z)-2-(2,6-difluorophenyl)-4-
(methoxymethoxy)but-2-enyl ester (2.13 mmol, 1.0 equiv.) in DMF (3.5 mL) to give 
(±)-methyl (E)-4-(2,6-difluorophenyl)-6-(methoxymethoxy)-2-(N-(2,4,6-
triisopropylphenylsulfonyl)phenylsulfonimidoyl)hex-4-enoate as a colourless gum, 





















According to general procedure E, (±)-methyl (E)-4-(2,6-difluorophenyl)-6-
(methoxymethoxy)-2-(N-(2,4,6-triisopropylphenylsulfonyl)phenylsulfonimidoyl)hex-
4-enoate (2.13 mmol, 1.0 equiv.) in MeCN (22 mL) was treated with 2 M aq. HCl (4.5 
mL). Purification by chromatography (20→40% EtOAc–petrol) gave (±)-methyl (E)-
4-(2,6-difluorophenyl)-6-hydroxy-2-(N-(2,4,6-triisopropylphenylsulfonyl)phenylsul-
fonimidoyl)hex-4-enoate (491 mg, 33% over two steps) as a colourless gum; Rf 0.36 
(50% EtOAc–heptane); max (film) 2958, 1744, 1621, 1462, 1316, 1237, 1150, 1095, 
1057 cm
-1
; H (400 MHz) 7.90 (2H, d, J 8.0 Hz, o-Ph), 7.72 (1H, m, p-Ph), 7.58 (2H, 
m, m-Ph), 7.22 (1H, m, o-ArF), 7.09 (2H, s, m-SO2Ar), 6.86 (2H, 2 × t, J 8.0 Hz, m-
ArF), 5.84 (1H, 2 × t, J 6.5 Hz, CHCH2OH), 4.64 (1H, dd, J 12.0, 3.0 Hz, SCH), 4.37 
54 
(1H, dd, J 11.0, 4.5 Hz, SCH),  4.29 (2H, m, CH2OH), 4.25 (2H, m, o-ArCH), [3.58, 
3.47] (3H, 2 × s, OCH3), [3.25, 3.18] (1H, 2 × dd, J 13.5, 2.0 Hz, SCHCH2), [3.15, 
3.00] (1H, 2 × d, J 12.0 Hz, SCHCH2), 2.86 (1H, 2 × sept, J 7.0 Hz, p-ArCH), 2.05 
(1H, br s, OH), 1.20 (18H, m, CH(CH3)2); C (100 MHz) 165.5, 165.3 (C=O), 161.4, 
158.9 (CF), 152.2, 152.1, 149.2, 149.1, 137.7, 137.5, 134.1, 129.4 (4°), 137.1, 136.9 
(CHCH2OH), 134.9, 134.8, 129.6, 129.5, 129.3, 129.2, 123.4 (3°), 124.1, 124.0 
(CFCHCH), 117.1 (CCF), 111.7, 111.6, 111.5, 111.3 (CFCHCH), 70.4, 70.1 (SCH), 
58.6, 58.5 (CH2OH), 53.2, 53.1 (OCH3), 34.1 (p-ArCH), 29.3 (o-ArCH), 29.0, 27.8 
(SCHCH2), 24.6, 24.6 (o-ArCH(CH3)2), 23.6 (p-ArCH(CH3)2); m/z (CI) 679 
[M+NH4]
+
, 586, 425, 301, 272 (Found [M+H]
+
, 662.2416. C34H41F2NO6S2 requires 
[M+H]
+
, 662.2422) (Found: C, 61.77; H, 6.18; N, 2.11. C34H41F2NO6S2 requires C, 





















According to general procedure F, a solution of (±)-methyl (E)-4-(2,6-
difluorophenyl)-6-hydroxy-2-(N-(2,4,6-triisopropylphenylsulfonyl)phenylsulfon-
imidoyl)hex-4-enoate (491 mg, 0.74 mmol, 1.0 equiv.) in THF (1.85 mL) was treated 
with 2 M aq. LiOH (1.85 mL) to give (±)-(E)-4-(2,6-difluorophenyl)-6-hydroxy-2-(N-
(2,4,6-triisopropylphenylsulfonyl)phenylsulfonimidoyl)hex-4-enoic (402 mg, 84%) as 
a colourless foam, which was used without further purification; max (film) 3427, 
2961, 2929, 2870, 1707, 1622, 1599, 1463, 1398, 1265, 1232, 1146, 1095, 1064, 
1021, 998, 738 cm
-1
; H (400 MHz; CD3OD) 7.80 (2H, d, J 7.5 Hz, o-Ph), 7.71 (1H, 2 
× t, J 7.5 Hz, p-Ph), 7.53 (2H, 2 × t, J 7.5 Hz, m-Ph), 7.31 (1H, m, o-ArF), [7.14, 
7.13] (2H, 2 × s, m-SO2Ar), 6.92 (2H, 2 × t, J 8.0 Hz, m-ArF), [5.80, 5.74] (1H, 2 × t, 
J 6.5 Hz, CHCH2OH), [4.39, 4.29] (2H, 2 × dd, J 13.5, 7.0 Hz, CH2OH), 4.17 (2H, 2 
× sept, J 6.5 Hz, o-ArCH), 3.96 (1H, d, J 11.5 Hz, SCH), [3.44, 3.22, 2.85] (2H, 3 × 
m, SCHCH2), 2.91 (1H, 2 × sept, J 7.0 Hz, p-ArCH), 1.18–1.10 (18H, m, CH(CH3)2); 
C (100 MHz; CD3OD) 169.0, 168.7 (C=O), 162.9, 160.5 (CF), 153.7, 153.5, 150.5, 
55 
150.4, 138.7, 138.1, 135.8, 129.4 (4°), 137.9, 137.4, 136.9, 135.4, 135.3, 130.8, 130.6, 
130.4, 130.2, 130.1, 126.8, 126.6 (3°), 124.4 (CFCHCH), 119.2, 119.0, 118.8 (CCF), 
112.8, 112.7, 112.7, 112.5, 112.5 (CFCHCH), 74.6 (SCH), 59.2, 59.1 (CH2OH), 35.4 
(p-ArCH), 30.3 (o-ArCH), 25.1, 25.0, 24.9 (o-ArCH(CH3)2), 24.1 (p-ArCH(CH3)2); 
m/z (CI) 621 [M-CO2+NH4]
+





, 621.2632) (Found: C, 61.18; H, 6.14; N, 2.16. 























According to general procedure G, (±)-(E)-4-(2,6-difluorophenyl)-6-hydroxy-2-(N-
(2,4,6-triisopropylphenylsulfonyl)phenylsulfonimidoyl)hex-4-enoic (360 mg, 0.56 
mmol, 1.0 equiv.) in CH2Cl2 (2.8 mL) at 0 °C was treated with EDCI (118 mg, 0.62 
mmol, 1.1 equiv.). Purification by chromatography (30% EtOAc–petrol) (±)-5-(2,6-
difluorophenyl)-3-(N-(2,4,6-triisopropylphenylsulfonyl)phenylsulfonimidoyl)-4,7-
dihydrooxepin-2(3H)-one 23c (289 mg, 82%) as a colourless solid; mp 86–87 °C; Rf 
0.69 (50% EtOAc–petrol); max (film) 2959, 1756, 1623, 1599, 1464, 1401, 1267, 
1234, 1148, 1092, 1064, 1023, 998, 738 cm
-1
; H (400 MHz) 8.12 (2H, 2 × d, J 8.5 
Hz, o-Ph), 7.69 (1H,  2 × t, J 8.5 Hz, p-Ph), 7.56 (2H, 2 × t, J 8.0 Hz, m-Ph), 7.27 (1H, 
m, o-ArF), [7.12, 7.10] (2H, 2 × s, m-SO2Ar), 6.91 (2H, m, m-ArF), 5.98 (1H, m, 
CHCH2O), [5.96, 5.90] (1H, 2 × dd, J 13.0, 3.5 Hz, SCH), [5.27, 5.21] (1H, 2 × ddd, 
16.0, 13.0, 3.5 Hz, OCH2), 4.68 (1H, ddd, J 16.0, 7.5, 4.5 Hz, OCH2), 4.3 (2H, sept, J 
6.5 Hz, o-ArCH), [3.54, 3.36] (1H, 2 × d, J 17.5 Hz, SCHCH2), 2.88 (1H, sept, J 6.5 
Hz, p-ArCH), 2.78 (1H, m, SCHCH2) 1.27–1.12 (18H, m, CH(CH3)2); C (100 MHz) 
166.0, 165.9 (C=O), 161.0, 161.0, 160.9, 158.6, 158.5, 158.4 (CF), 152.3, 152.2, 
149.3, 149.0, 137.1, 136.6, 134.9, 133.7, 133.6, (4°), 131.0, 130.9, 130.1, 130.0, 129.9 
(CFCHCH), 128.9, 128.8, 127.9, 127.7, 123.5 (3°), 117.7, 117.6, 117.5, 117.4, 117.3, 
117.2 (CCF), 112.0, 111.9, 111.7, 111.7 (CFCHCH), 66.0, 65.4 (SCH), 63.8, 63.7 
56 
(OCH2), 34.1 (p-ArCH), 31.7, 30.5 (SCHCH2), 29.3 (o-ArCH), 24.7, 24.5 (o-
ArCH(CH3)2), 23.6 (p-ArCH(CH3)2); m/z (CI) 647 [M+NH4]
+
, 603, 586, 425, 370, 
352, 335, 301, 240 (Found [M+NH4]
+
, 647.2405. C33H37F2NO5S2 requires [M+NH4]
+
, 
647.2425) (Found: C, 62.83; H, 5.85; N, 2.15. C33H37F2NO5S2 requires C, 62.94; H, 











































According to general procedure H, lactone 23c (74 mg, 0.12 mmol, 1.0 equiv.) in 
DMF (0.6 mL) was treated with KOAc (1.2 mg, 0.012 mmol, 0.1 equiv.) and BSA (29 
μL, 0.12 mmol, 1.0 equiv.). Purification by chromatography (10–20% Et2O–petrol) 
gave the sulfoximines 24c–27c as a colourless gum (56 mg, 78%) as an inseparable 
mixture of diastereoisomers (ratio 24c:25c:26c:27c = 49:11:36:4); Rf 0.75 (50% 
EtOAc–petrol); max (film) 2960, 2869, 1625, 1599, 1585, 1467, 1448, 1312, 1296, 
1236, 1148, 1100, 1052, 1006, 910, 788, 772, 735, 684 cm
–1
; H (500 MHz) [8.09, 
8.02] (2H, 2 × d, J 7.5 Hz, o-Ph), 7.71–7.47 (m, Ph), 7.24 (m, Ph), [7.14, 7.08] (2H, 2 
× s, SO2Ar), 6.84 (2H, t, J 8.0 Hz, m-ArF), 6.56 (1H, t, J 8.0 Hz, p-ArF), 6.42 (1H, 
dd, J 17.0, 10.5 Hz, CH=CH2 24c), 6.11 (1H, dd, J 17.0, 10.5 Hz, CH=CH2 25c), 5.62 
(1H, dd, J 17.0, 10.5 Hz, CH=CH2 27c), 5.59 (1H, dd, J 17.0, 10.5 Hz, CH=CH2 26c), 
5.18 (1H, d, J 10.5 Hz, CH=CH2 cis 24c), 5.10 (1H, d, J 10.5 Hz, CH=CH2 cis 27c), 
57 
5.09 (1H, d, J 10.5 Hz, CH=CH2 cis 25c), 5.06 (1H, d, J 10.5 Hz, CH=CH2 cis 26c), 
4.87 (1H, d, J 17.0 Hz, CH=CH2 trans 27c), 4.80 (1H, d, J 17.0 Hz, CH=CH2 trans 
26c), 4.70 (1H, d, J 17.0 Hz, CH=CH2 trans 24c), 4.55 (1H, d, J 17.0 Hz, CH=CH2 
trans 25c), [4.44, 4.39, 4.30] (2H, 3 × sept, J 6.5 Hz, o-ArCH), [3.40, 2.94, 2.82] (1H, 
3 × m, SCH), 2.91 (1H, sept, J 6.5 Hz, p-ArCH), [2.51, 2.38] (1H, 4 × dd, J 6.5, 6.5 
Hz, SCHCH2), [2.11, 1.82] (1H, 2 × dd, J 9.0, 7.0 Hz, SCHCH2), 1.30–1.19 (18H, m, 
CH(CH3)2);C (125 MHz) 162.4, 162.4, 160.4, 160.4 (CF), 151.8, 149.3, 149.0, 
139.8, 137.8, 137.7, 137.6, 137.1 (4°), 133.8, 133.3 (CH=CH2), 129.2, 128.9, 128.4, 
127.7, 123.3, 123.2, 123.2 (3°), 130.2, 130.1, 130.0, 129.9, 129.8, 129.7 (CFCHCH), 
118.3, 115.5 (CH=CH2), 112.2, 112.0, 111.8, 111.6, 111.2, 111.0 (CFCHCH), 49.2, 
46.0 (SCH), 34.1 (p-ArCH), 29.8, 29.7, 29.5 29.3, 29.2, 29.1 (o-ArCH), 24.9, 24.7, 
24.7, 24.6, 24.6 23.8, 23.8, 23.7, 23.6 (CH(CH3)2), 20.2, 18.5, 18.4 (SCHCH2); m/z 
(CI) 603 [M+NH4]
+
, 586, 425 (Found [M+H]
+
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